198904-31-3
[1]Patent:WO2010/146119,2010,A1.Locationinpatent:Page/Pagecolumn9-11
[2]OrganicProcessResearchandDevelopment,2002,vol.6,p.323-328
[3]JournalofMedicinalChemistry,1998,vol.41,p.3387-3401
[1]Journaloflabelledcompoundsandradiopharmaceuticals,2005,vol.48,p.1041-1047
[1]Journaloflabelledcompoundsandradiopharmaceuticals,2005,vol.48,p.1041-1047
[1]Journaloflabelledcompoundsandradiopharmaceuticals,2005,vol.48,p.1041-1047
[2]OrganicProcessResearchandDevelopment,2008,vol.12,p.69-75
[1]Journaloflabelledcompoundsandradiopharmaceuticals,2005,vol.48,p.1041-1047
Title: Effects of antiretroviral treatment on paraoxonase 1 (PON1) activity in rats.
Journal: Chemico-biological interactions 20161125
Title: Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
Journal: Chemical research in toxicology 20150518
Title: GS-8374, a prototype phosphonate-containing inhibitor of HIV-1 protease, effectively inhibits protease mutants with amino acid insertions.
Journal: Journal of virology 20140301
Title: Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP/ABCB11).
Journal: Toxicological sciences : an official journal of the Society of Toxicology 20131201
Title: GRL-04810 and GRL-05010, difluoride-containing nonpeptidic HIV-1 protease inhibitors (PIs) that inhibit the replication of multi-PI-resistant HIV-1 in vitro and possess favorable lipophilicity that may allow blood-brain barrier penetration.
Journal: Antimicrobial agents and chemotherapy 20131201
Title: Substrate envelope-designed potent HIV-1 protease inhibitors to avoid drug resistance.
Journal: Chemistry & biology 20130919
Title: GRL-0519, a novel oxatricyclic ligand-containing nonpeptidic HIV-1 protease inhibitor (PI), potently suppresses replication of a wide spectrum of multi-PI-resistant HIV-1 variants in vitro.
Journal: Antimicrobial agents and chemotherapy 20130501
Title: Cellular pharmacology and potency of HIV-1 nucleoside analogs in primary human macrophages.
Journal: Antimicrobial agents and chemotherapy 20130301
Title: Synthesis, 2D-NMR and molecular modelling studies of pentacycloundecane lactam-peptides and peptoids as potential HIV-1 wild type C-SA protease inhibitors.
Journal: Journal of enzyme inhibition and medicinal chemistry 20130201
Title: In vitro and structural evaluation of PL-100 as a potential second-generation HIV-1 protease inhibitor.
Journal: The Journal of antimicrobial chemotherapy 20130101
Title: Mutations in multiple domains of Gag drive the emergence of in vitro resistance to the phosphonate-containing HIV-1 protease inhibitor GS-8374.
Journal: Journal of virology 20130101
Title: Design and synthesis of HIV-1 protease inhibitors for a long-acting injectable drug application.
Journal: Bioorganic & medicinal chemistry letters 20130101
Title: [Cushing's syndrome during HIV treatment: pharmacological interaction during use of ritonavir].
Journal: Nederlands tijdschrift voor geneeskunde 20130101
Title: Effect of HIV protease inhibitors on New World Leishmania.
Journal: Parasitology international 20121201
Title: Relation between flexibility and positively selected HIV-1 protease mutants against inhibitors.
Journal: Proteins 20121201
Title: Pharmacodynamic and antiretroviral activities of combination nanoformulated antiretrovirals in HIV-1-infected human peripheral blood lymphocyte-reconstituted mice.
Journal: The Journal of infectious diseases 20121115
Title: Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice.
Journal: AIDS (London, England) 20121113
Title: Novel method to assess antiretroviral target trough concentrations using in vitro susceptibility data.
Journal: Antimicrobial agents and chemotherapy 20121101
Title: Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patients.
Journal: Clinical pharmacology and therapeutics 20121101
Title: Treatment of HIV infection with once-daily regimens.
Journal: Expert opinion on pharmacotherapy 20121101
Title: Virological efficacy and safety of antiretroviral therapy-switch to atazanavir-based regimen: a review of the literature.
Journal: Expert opinion on pharmacotherapy 20121101
Title: The protease inhibitor atazanavir triggers autophagy and mitophagy in human preadipocytes.
Journal: AIDS (London, England) 20121023
Title: Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks.
Journal: AIDS research and human retroviruses 20121001
Title: A population pharmacokinetic-pharmacogenetic analysis of atazanavir.
Journal: AIDS research and human retroviruses 20121001
Title: Simplification to dual antiretroviral therapy including a ritonavir-boosted protease inhibitor in treatment-experienced HIV-1-infected patients.
Journal: The Journal of antimicrobial chemotherapy 20121001
Title: Antiretroviral neurotoxicity.
Journal: Journal of neurovirology 20121001
Title: Anti-retroviral drugs do not facilitate hepatitis C virus (HCV) infection in vitro.
Journal: Antiviral research 20121001
Title: Short communication: UGT1A1*28 variant allele is a predictor of severe hyperbilirubinemia in HIV-infected patients on HAART in southern Brazil.
Journal: AIDS research and human retroviruses 20120901
Title: Short communication: Phenotypic protease inhibitor resistance and cross-resistance in the clinic from 2006 to 2008 and mutational prevalences in HIV from patients with discordant tipranavir and darunavir susceptibility phenotypes.
Journal: AIDS research and human retroviruses 20120901
Title: HIV-HCV co-infection facing HCV protease inhibitor licensing: implications for clinicians.
Journal: Liver international : official journal of the International Association for the Study of the Liver 20120901
Title: Switching to unboosted atazanavir reduces bilirubin and triglycerides without compromising treatment efficacy in UGT1A1*28 polymorphism carriers.
Journal: The Journal of antimicrobial chemotherapy 20120901
Title: Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study.
Journal: Scandinavian journal of infectious diseases 20120901
Title: Effect of cobicistat on glomerular filtration rate in subjects with normal and impaired renal function.
Journal: Journal of acquired immune deficiency syndromes (1999) 20120901
Title: Drug interaction profile for GSK2248761, a next generation non-nucleoside reverse transcriptase inhibitor.
Journal: British journal of clinical pharmacology 20120801
Title: Effects of hepatitis C virus infection on the pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected patients.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20120801
Title: Prevalence of nephrolithiasis in human immunodeficiency virus infected patients on the highly active antiretroviral therapy.
Journal: Journal of endourology 20120801
Title: Boosting of HIV protease inhibitors by ritonavir in the intestine: the relative role of cytochrome P450 and P-glycoprotein inhibition based on Caco-2 monolayers versus in situ intestinal perfusion in mice.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20120801
Title: Ritonavir boosting dose reduction from 100 to 50 mg does not change the atazanavir steady-state exposure in healthy volunteers.
Journal: The Journal of antimicrobial chemotherapy 20120801
Title: Vector replication and expression of HIV-1 antigens by the HIV/AIDS vaccine candidate MVA-B is not affected by HIV-1 protease inhibitors.
Journal: Virus research 20120801
Title: Enamino-oxindole HIV protease inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20120801
Title: [A single tablet against HIV: new combination preparation improves therapy].
Journal: Deutsche medizinische Wochenschrift (1946) 20120801
Title: Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings.
Journal: PLoS medicine 20120801
Title: Assessing the effectiveness of antiretroviral regimens in cohort studies involving HIV-positive injection drug users.
Journal: AIDS (London, England) 20120731
Title: Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.
Journal: JAMA 20120725
Title: Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir.
Journal: AIDS (London, England) 20120717
Title: Synthesis and molecular modelling studies of novel carbapeptide analogs for inhibition of HIV-1 protease.
Journal: European journal of medicinal chemistry 20120701
Title: Tenofovir: quo vadis anno 2012 (where is it going in the year 2012)?
Journal: Medicinal research reviews 20120701
Title: Monotherapy with atazanavir as a simplification strategy: results from an observational study.
Journal: Journal of acquired immune deficiency syndromes (1999) 20120701
Title: Optimising the manufacture, formulation, and dose of antiretroviral drugs for more cost-efficient delivery in resource-limited settings: a consensus statement.
Journal: The Lancet. Infectious diseases 20120701
Title: The dual role of pharmacogenetics in HIV treatment: mutations and polymorphisms regulating antiretroviral drug resistance and disposition.
Journal: Pharmacological reviews 20120701
Title: Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors.
Journal: International journal of STD & AIDS 20120701
Title: Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial.
Journal: Lancet (London, England) 20120630
Title: Unboosted atazanavir for treatment of HIV infection: rationale and recommendations for use.
Journal: Drugs 20120618
Title: The effect of HIV protease inhibitors on amyloid-β peptide degradation and synthesis in human cells and Alzheimer's disease animal model.
Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 20120601
Title: Overall benefit of antiretroviral treatment on the risk of fracture in HIV: nested case-control analysis in a health-insured population.
Journal: AIDS (London, England) 20120601
Title: HIV therapies and the kidney: some good, some not so good?
Journal: Current HIV/AIDS reports 20120601
Title: Monitoring the risk of birth defects associated with atazanavir exposure in pregnancy.
Journal: AIDS patient care and STDs 20120601
Title: A randomized study of pharmacokinetics, efficacy, and safety of 2 raltegravir plus atazanavir strategies in ART-treated adults.
Journal: Journal of acquired immune deficiency syndromes (1999) 20120601
Title: Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Journal: Journal of medicinal chemistry 20120524
Title: HIV-1 protease mutation 82M contributes to phenotypic resistance to protease inhibitors in subtype G.
Journal: The Journal of antimicrobial chemotherapy 20120501
Title: Clinical significance of hyperbilirubinemia among HIV-1-infected patients treated with atazanavir/ritonavir through 96 weeks in the CASTLE study.
Journal: AIDS patient care and STDs 20120501
Title: The pharmacokinetics of lersivirine (UK-453,061) and HIV-1 protease inhibitor coadministration in healthy subjects.
Journal: Journal of acquired immune deficiency syndromes (1999) 20120501
Title: Atypical pharmacokinetics of atazanavir in an HIV-1-infected patient.
Journal: Fundamental & clinical pharmacology 20120401
Title: Virological response and resistance profiles after 24 months of first-line antiretroviral treatment in adults living in Bangui, Central African Republic.
Journal: AIDS research and human retroviruses 20120401
Title: Dynamics of cognitive change in HIV-infected individuals commencing three different initial antiretroviral regimens: a randomized, controlled study.
Journal: HIV medicine 20120401
Title: Prediction and in vitro evaluation of selected protease inhibitor antiviral drugs as inhibitors of carboxylesterase 1: a potential source of drug-drug interactions.
Journal: Pharmaceutical research 20120401
Title: Atazanavir: in pediatric patients with HIV-1 infection.
Journal: Paediatric drugs 20120401
Title: The role of polymorphisms at position 89 in the HIV-1 protease gene in the development of drug resistance to HIV-1 protease inhibitors.
Journal: The Journal of antimicrobial chemotherapy 20120401
Title: Viremia and HIV-1 drug resistance mutations among patients receiving second-line highly active antiretroviral therapy in Chennai, Southern India.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120401
Title: Intrapatient and interpatient pharmacokinetic variability of raltegravir in the clinical setting.
Journal: Therapeutic drug monitoring 20120401
Title: HIV exposure through contact with body fluids.
Journal: Prescrire international 20120401
Title: Nanotechnology and the treatment of HIV infection.
Journal: Viruses 20120401
Title: Library-based discovery and characterization of daphnane diterpenes as potent and selective HIV inhibitors in Daphne gnidium.
Journal: Journal of natural products 20120323
Title: Synthesis, X-ray analysis, and biological evaluation of a new class of stereopure lactam-based HIV-1 protease inhibitors.
Journal: Journal of medicinal chemistry 20120322
Title: A review of the virological efficacy of the 4 World Health Organization-recommended tenofovir-containing regimens for initial HIV therapy.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120315
Title: Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir.
Journal: AIDS (London, England) 20120313
Title: Spontaneously reported hepatic adverse drug events in Korea: multicenter study.
Journal: Journal of Korean medical science 20120301
Title: Comparison of extraction procedures for assessment of matrix effect for selective and reliable determination of atazanavir in human plasma by LC-ESI-MS/MS.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120215
Title: Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific.
Journal: International journal of epidemiology 20120201
Title: In vitro and in silico strategies to identify OATP1B1 inhibitors and predict clinical drug-drug interactions.
Journal: Pharmaceutical research 20120201
Title: Different baseline characteristics and different outcomes of HIV-infected patients receiving HAART through clinical trials compared with routine care in Mexico.
Journal: Journal of acquired immune deficiency syndromes (1999) 20120201
Title: Pharmacokinetics and inhibitory quotient of atazanavir/ritonavir versus lopinavir/ritonavir in HIV-infected, treatment-naive patients who participated in the CASTLE Study.
Journal: The Journal of antimicrobial chemotherapy 20120201
Title: FOLFIRI plus bevacizumab 5 mg/kg versus 10 mg/kg as second-line therapy in patients with metastatic colorectal cancer who have failed first-line bevacizumab plus oxaliplatin-based therapy: a randomized phase III study (EAGLE Study).
Journal: Japanese journal of clinical oncology 20120201
Title: Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers.
Journal: Scandinavian journal of gastroenterology 20120201
Title: Severe atazanavir-associated hyperbilirubinemia revealing Canton G6PD deficiency in an Asian HIV-infected patient.
Journal: AIDS (London, England) 20120114
Title: In vivo enhancement in bioavailability of atazanavir in the presence of proton-pump inhibitors using mesoporous materials.
Journal: ChemMedChem 20120102
Title: HIV type 1 viral encephalitis after development of viral resistance to plasma suppressive antiretroviral therapy.
Journal: AIDS research and human retroviruses 20120101
Title: Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution.
Journal: International journal of vascular medicine 20120101
Title: A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz.
Journal: Journal of acquired immune deficiency syndromes (1999) 20120101
Title: Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study.
Journal: The Lancet. Infectious diseases 20120101
Title: Unexpected atazanavir-associated biliary lithiasis in an HIV-infected patient.
Journal: The Journal of antimicrobial chemotherapy 20120101
Title: Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy.
Journal: PloS one 20120101
Title: HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART.
Journal: Advances in hematology 20120101
Title: Effects of ritonavir-boosted darunavir, atazanavir and lopinavir on adipose functions and insulin sensitivity in murine and human adipocytes.
Journal: Antiviral therapy 20120101
Title: Post-exposure prophylaxis for HIV infection: a clinical trial comparing lopinavir/ritonavir versus atazanavir each with zidovudine/lamivudine.
Journal: Antiviral therapy 20120101
Title: Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz.
Journal: BMC infectious diseases 20120101
Title: Review of the safety, efficacy, and pharmacokinetics of elvitegravir with an emphasis on resource-limited settings.
Journal: HIV/AIDS (Auckland, N.Z.) 20120101
Title: Virologic failures on initial boosted-PI regimen infrequently possess low-level variants with major PI resistance mutations by ultra-deep sequencing.
Journal: PloS one 20120101
Title: Impact of the herbal medicine Sophora flavescens on the oral pharmacokinetics of indinavir in rats: the involvement of CYP3A and P-glycoprotein.
Journal: PloS one 20120101
Title: Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial.
Journal: BMC gastroenterology 20120101
Title: HIV-associated gastric natural killer/T-cell lymphoma.
Journal: International journal of STD & AIDS 20120101
Title: Immune reconstitution renal-limited sarcoidosis presenting as acute kidney injury.
Journal: International journal of STD & AIDS 20120101
Title: Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States.
Journal: PloS one 20120101
Title: A randomized comparative 96-week trial of boosted atazanavir versus continued boosted protease inhibitor in HIV-1 patients with abdominal adiposity.
Journal: Antiviral therapy 20120101
Title: Rosuvastatin: a review of the pharmacology and clinical effectiveness in cardiovascular disease.
Journal: Clinical Medicine Insights. Cardiology 20120101
Title: Physiological antioxidative network of the bilirubin system in aging and age-related diseases.
Journal: Frontiers in pharmacology 20120101
Title: The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases.
Journal: Frontiers in pharmacology 20120101
Title: HIV-1 phenotypic reverse transcriptase inhibitor drug resistance test interpretation is not dependent on the subtype of the virus backbone.
Journal: PloS one 20120101
Title: Novel therapeutic strategies targeting HIV integrase.
Journal: BMC medicine 20120101
Title: HIV-Antiretroviral Therapy Induced Liver, Gastrointestinal, and Pancreatic Injury.
Journal: International journal of hepatology 20120101
Title: Evaluation of inadequate anti-retroviral treatment in patients with HIV/AIDS.
Journal: Revista da Sociedade Brasileira de Medicina Tropical 20120101
Title: The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review.
Journal: Patient preference and adherence 20120101
Title: Pharmacokinetics and Pharmacodynamics of Darunavir and Etravirine in HIV-1-Infected, Treatment-Experienced Patients in the Gender, Race, and Clinical Experience (GRACE) Trial.
Journal: AIDS research and treatment 20120101
Title: Economic and health-related quality-of-life (HRQoL) comparison of lopinavir/ritonavir (LPV/r) and atazanavir plus ritonavir (ATV+RTV) based regimens for antiretroviral therapy (ART)-naïve and -experienced United Kingdom patients in 2011.
Journal: Journal of medical economics 20120101
Title: Low-cost ultra-wide genotyping using Roche/454 pyrosequencing for surveillance of HIV drug resistance.
Journal: PloS one 20120101
Title: Interactions between phytochemical components of Sutherlandia frutescens and the antiretroviral, atazanavir in vitro: implications for absorption and metabolism.
Journal: Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20120101
Title: Heme oxygenase, inflammation, and fibrosis: the good, the bad, and the ugly?
Journal: Frontiers in pharmacology 20120101
Title: Impact of low-level-viremia on HIV-1 drug-resistance evolution among antiretroviral treated-patients.
Journal: PloS one 20120101
Title: A nucleoside- and ritonavir-sparing regimen containing atazanavir plus raltegravir in antiretroviral treatment-naïve HIV-infected patients: SPARTAN study results.
Journal: HIV clinical trials 20120101
Title: Prevalence of Drug Resistance and Associated Mutations in a Population of HIV-1(+) Puerto Ricans: 2006-2010.
Journal: AIDS research and treatment 20120101
Title: Trends in Decline of Antiretroviral Resistance among ARV-Experienced Patients in the HIV Outpatient Study: 1999-2008.
Journal: AIDS research and treatment 20120101
Title: Measuring the efficacy of antiretroviral therapy.
Journal: International journal of trichology 20120101
Title: Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells.
Journal: International journal of nanomedicine 20120101
Title: Antiretroviral simplification with darunavir/ritonavir monotherapy in routine clinical practice: safety, effectiveness, and impact on lipid profile.
Journal: PloS one 20120101
Title: Differences in lipid measurements by antiretroviral regimen exposure in cohorts from Asia and australia.
Journal: AIDS research and treatment 20120101
Title: All-Trans Retinoic Acid-Induced Pseudotumor Cerebri during Induction Therapy for Acute Promyelocytic Leukemia: A Case Report and Literature Review.
Journal: Case reports in oncological medicine 20120101
Title: Antiretroviral drugs: critical issues and recent advances.
Journal: Indian journal of pharmacology 20120101
Title: Hypophosphatemic Osteomalacia Associated with Tenofovir: a Multidisciplinary Approach is Required.
Journal: Mediterranean journal of hematology and infectious diseases 20120101
Title: Malaria and hiv in adults: when the parasite runs into the virus.
Journal: Mediterranean journal of hematology and infectious diseases 20120101
Title: Diffuse tubulointerstitial nephritis accompanied by renal crystal formation in an HIV-infected patient undergoing highly active antiretroviral therapy.
Journal: Internal medicine (Tokyo, Japan) 20120101
Title: Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV: experience in a pediatric population.
Journal: BMC infectious diseases 20120101
Title: Dosage optimization of treatments using population pharmacokinetic modeling and simulation.
Journal: Chimia 20120101
Title: Population pharmacokinetics of atazanavir/ritonavir in HIV-1-infected children and adolescents.
Journal: British journal of clinical pharmacology 20111201
Title: Human immunodeficiency virus type 1 endocytic trafficking through macrophage bridging conduits facilitates spread of infection.
Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 20111201
Title: Bilirubin-a potential marker of drug exposure in atazanavir-based antiretroviral therapy.
Journal: The AAPS journal 20111201
Title: Non-linear mixed effects modeling of antiretroviral drug response after administration of lopinavir, atazanavir and efavirenz containing regimens to treatment-naïve HIV-1 infected patients.
Journal: Journal of pharmacokinetics and pharmacodynamics 20111201
Title: HIV protease inhibitors induce metabolic dysfunction in part via increased JNK1/2 pro-inflammatory signaling in L6 cells.
Journal: Antiviral research 20111201
Title: A randomised comparison of safety and efficacy of nevirapine vs. atazanavir/ritonavir combined with tenofovir/emtricitabine in treatment-naïve patients.
Journal: International journal of clinical practice 20111201
Title: Additional explanation for lack of pharmacodynamic interaction between atazanavir and buprenorphine reported by Vergara-Rodriquez et al.
Journal: Journal of acquired immune deficiency syndromes (1999) 20111201
Title: Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Journal: PLoS computational biology 20111201
Title: The Relationship among Homocysteine, Bilirubin, and Diabetic Retinopathy.
Journal: Diabetes & metabolism journal 20111201
Title: Antiretroviral therapy in Indian setting: when & what to start with, when & what to switch to?
Journal: The Indian journal of medical research 20111201
Title: Diagnosis & treatment of tuberculosis in HIV co-infected patients.
Journal: The Indian journal of medical research 20111201
Title: How much do antiretroviral drugs penetrate into the central nervous system?
Journal: Journal of medicine and life 20111114
Title: Treatment of advanced HIV disease in antiretroviral-naïve HIV-1-infected patients receiving once-daily atazanavir/ritonavir or twice-daily lopinavir/ritonavir, each in combination with tenofovir disoproxil fumarate and emtricitabine.
Journal: AIDS care 20111101
Title: Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients.
Journal: HIV medicine 20111101
Title: Prediction of drug-resistance in HIV-1 subtype C based on protease sequences from ART naive and first-line treatment failures in North India using genotypic and docking analysis.
Journal: Antiviral research 20111101
Title: In vitro activity of antiretroviral drugs against Plasmodium falciparum.
Journal: Antimicrobial agents and chemotherapy 20111101
Title: On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds.
Journal: Nature chemical biology 20111101
Title: Concurrent atazanavir and voriconazole in a patient with multidrug-resistant HIV and a mycetoma.
Journal: AIDS (London, England) 20111023
Title: Impact of switching from lopinavir/ritonavir to atazanavir/ritonavir on body fat redistribution in virologically suppressed HIV-infected adults.
Journal: AIDS research and human retroviruses 20111001
Title: Clinical pharmacology profile of raltegravir, an HIV-1 integrase strand transfer inhibitor.
Journal: Journal of clinical pharmacology 20111001
Title: Short communication: use of serum bilirubin levels as surrogate marker of early virological response to atazanavir-based antiretroviral therapy.
Journal: AIDS research and human retroviruses 20111001
Title: Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women.
Journal: HIV medicine 20111001
Title: Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy.
Journal: The Journal of antimicrobial chemotherapy 20111001
Title: Population pharmacokinetics of lopinavir/ritonavir (Kaletra) in HIV-infected patients.
Journal: Therapeutic drug monitoring 20111001
Title: Simplified human immunodeficiency virus maintenance therapy in virologically suppressed children with Ritonavir-boosted protease inhibitor monotherapy.
Journal: The Pediatric infectious disease journal 20111001
Title: Iatrogenic Cushing syndrome after a single intramuscular corticosteroid injection and concomitant protease inhibitor therapy.
Journal: Journal of the American Academy of Dermatology 20111001
Title: Phase 2 study of cobicistat versus ritonavir each with once-daily atazanavir and fixed-dose emtricitabine/tenofovir df in the initial treatment of HIV infection.
Journal: AIDS (London, England) 20110924
Title: [Drug-drug interactions with HIV treatments].
Journal: Praxis 20110921
Title: Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.
Journal: Annals of internal medicine 20110920
Title: Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.
Journal: Annals of internal medicine 20110920
Title: [Human immunodeficiency virus and Chagas disease coinfection treated successfully with benznidazole and a raltegravir-based antiretroviral regimen: a case report].
Journal: Medicina clinica 20110910
Title: Evaluation of antiretroviral-related errors and interventions by the clinical pharmacist in hospitalized HIV-infected patients.
Journal: HIV medicine 20110901
Title: Structural features determining the intestinal epithelial permeability and efflux of novel HIV-1 protease inhibitors.
Journal: Journal of pharmaceutical sciences 20110901
Title: A retrospective study of HIV antiretroviral treatment persistence in a commercially insured population in the United States.
Journal: AIDS care 20110901
Title: Determination of rifabutin dosing regimen when administered in combination with ritonavir-boosted atazanavir.
Journal: The Journal of antimicrobial chemotherapy 20110901
Title: Synthesis and structural studies of pentacycloundecane-based HIV-1 PR inhibitors: a hybrid 2D NMR and docking/QM/MM/MD approach.
Journal: European journal of medicinal chemistry 20110901
Title: Effects of the H2-receptor antagonist famotidine on the pharmacokinetics of atazanavir-ritonavir with or without tenofovir in HIV-infected patients.
Journal: AIDS patient care and STDs 20110901
Title: Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir.
Journal: AIDS (London, England) 20110824
Title: Medication-based urolithiasis and atazanavir.
Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20110809
Title: Exposure to HIV-protease inhibitors selects for increased expression of P-glycoprotein (ABCB1) in Kaposi's sarcoma cells.
Journal: British journal of cancer 20110809
Title: Outcomes of switch to atazanavir-containing combination antiretroviral therapy in HIV-1-infected patients with hyperlipidemia.
Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20110801
Title: Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy.
Journal: Kidney international 20110801
Title: UPLC-MS/MS quantification of nanoformulated ritonavir, indinavir, atazanavir, and efavirenz in mouse serum and tissues.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110801
Title: Optimizing antiretroviral product selection: a sample approach to improving patient outcomes, saving money, and scaling-up health services in developing countries.
Journal: Journal of acquired immune deficiency syndromes (1999) 20110801
Title: Prevalence of antiretroviral drug resistance mutations and HIV-I subtypes among newly-diagnosed drug-naïve persons visiting a voluntary testing and counselling centre in northeastern South Africa.
Journal: Journal of health, population, and nutrition 20110801
Title: Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescents.
Journal: AIDS (London, England) 20110731
Title: Effect of atazanavir and atazanavir/ritonavir on the pharmacokinetics of the next-generation HIV integrase inhibitor, S/GSK1349572.
Journal: British journal of clinical pharmacology 20110701
Title: Atazanavir in pregnancy: impact on neonatal hyperbilirubinemia.
Journal: European journal of obstetrics, gynecology, and reproductive biology 20110701
Title: Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study).
Journal: HIV medicine 20110701
Title: Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202.
Journal: The Journal of infectious diseases 20110615
Title: The HIV protease inhibitor nelfinavir inhibits Kaposi's sarcoma-associated herpesvirus replication in vitro.
Journal: Antimicrobial agents and chemotherapy 20110601
Title: Therapeutic drug monitoring of protease inhibitors and efavirenz in HIV-infected individuals with active substance-related disorders.
Journal: Therapeutic drug monitoring 20110601
Title: Therapeutic monitoring and variability of atazanavir in HIV-infected patients, with and without HCV coinfection, receiving boosted or unboosted regimens.
Journal: Therapeutic drug monitoring 20110601
Title: Cushing's syndrome due to antiretroviral-budesonide interaction.
Journal: The Annals of pharmacotherapy 20110601
Title: Management of HIV infection in treatment-naive patients: a review of the most current recommendations.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110601
Title: Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON).
Journal: Heart (British Cardiac Society) 20110515
Title: Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20110515
Title: [Persistence in focus. Atazanavir proves itself anew in long-term therapy].
Journal: MMW Fortschritte der Medizin 20110505
Title: HIV-1 integrase inhibitor resistance and its clinical implications.
Journal: The Journal of infectious diseases 20110501
Title: [Characteristics of antiretroviral drugs].
Journal: Enfermedades infecciosas y microbiologia clinica 20110501
Title: CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
Journal: PLoS pathogens 20110501
Title: Human immunodeficiency virus therapeutics and pharmacogenomics.
Journal: Indian journal of human genetics 20110501
Title: Gradient RP-HPLC method for the determination of potential impurities in atazanavir sulfate.
Journal: Journal of pharmaceutical and biomedical analysis 20110428
Title: The use of atazanavir in HIV-infected patients with liver cirrhosis: lack of hepatotoxicity and no significant changes in bilirubin values or model for end-stage liver disease score.
Journal: AIDS (London, England) 20110424
Title: Atazanavir pharmacokinetics with and without tenofovir during pregnancy.
Journal: Journal of acquired immune deficiency syndromes (1999) 20110415
Title: Pentacycloundecane-based inhibitors of wild-type C-South African HIV-protease.
Journal: Bioorganic & medicinal chemistry letters 20110415
Title: Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.
Journal: Annals of internal medicine 20110405
Title: Proper laboratory notebook practices: protecting your intellectual property.
Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 20110401
Title: Comparison of the influence of four classes of HIV antiretrovirals on adipogenic differentiation: the minimal effect of raltegravir and atazanavir.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20110401
Title: Cost-effectiveness of atazanavir/ritonavir compared with lopinavir/ritonavir in treatment-naïve human immunodeficiency virus-1 patients in Sweden.
Journal: Scandinavian journal of infectious diseases 20110401
Title: Tenofovir discontinuation could predispose to urolithiasis in atazanavir-treated patients.
Journal: The Journal of infection 20110401
Title: Pharmacokinetic interaction of vicriviroc with other antiretroviral agents: results from a series of fixed-sequence and parallel-group clinical trials.
Journal: Clinical pharmacokinetics 20110401
Title: The International Interlaboratory Quality Control Program for Measurement of Antiretroviral Drugs in Plasma: a global proficiency testing program.
Journal: Therapeutic drug monitoring 20110401
Title: Within-patient atazanavir trough concentration monitoring in HIV-1-infected patients.
Journal: Journal of pharmacy practice 20110401
Title: A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation.
Journal: Journal of pharmaceutical and biomedical analysis 20110325
Title: Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages.
Journal: Journal of controlled release : official journal of the Controlled Release Society 20110310
Title: Effect of low-dose omeprazole (20 mg daily) on the pharmacokinetics of multiple-dose atazanavir with ritonavir in healthy subjects.
Journal: Journal of clinical pharmacology 20110301
Title: Atazanavir metabolism according to CYP3A5 status: an in vitro-in vivo assessment.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20110301
Title: CYP3A-mediated generation of aldehyde and hydrazine in atazanavir metabolism.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20110301
Title: Detrimental effect of atazanavir plasma concentrations on total serum bilirubin levels in the presence of UGT1A1 polymorphisms.
Journal: Journal of acquired immune deficiency syndromes (1999) 20110301
Title: Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients.
Journal: Journal of acquired immune deficiency syndromes (1999) 20110301
Title: FDA notifications. FDA approves new atazanavir labeling.
Journal: AIDS alert 20110301
Title: Intestinal enzymatic metabolism of drugs.
Journal: The Journal of pharmacy and pharmacology 20110301
Title: Glyceroneogenesis is inhibited through HIV protease inhibitor-induced inflammation in human subcutaneous but not visceral adipose tissue.
Journal: Journal of lipid research 20110201
Title: The bilirubin-increasing drug atazanavir improves endothelial function in patients with type 2 diabetes mellitus.
Journal: Arteriosclerosis, thrombosis, and vascular biology 20110201
Title: Comparative gender analysis of the efficacy and safety of atazanavir/ritonavir and lopinavir/ritonavir at 96 weeks in the CASTLE study.
Journal: The Journal of antimicrobial chemotherapy 20110201
Title: Approach to dyslipidemia, lipodystrophy, and cardiovascular risk in patients with HIV infection.
Journal: Current atherosclerosis reports 20110201
Title: Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations.
Journal: AIDS (London, England) 20110128
Title: Design and synthesis of potent HIV-1 protease inhibitors incorporating hexahydrofuropyranol-derived high affinity P(2) ligands: structure-activity studies and biological evaluation.
Journal: Journal of medicinal chemistry 20110127
Title: Managing the atazanavir-tacrolimus drug interaction in a renal transplant recipient.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110115
Title: Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort study.
Journal: The Journal of infectious diseases 20110115
Title: The toxicogenetics of antiretroviral therapy: the evil inside.
Journal: Current medicinal chemistry 20110101
Title: HIV-infected adolescents: relationship between atazanavir plasma levels and bilirubin concentrations.
Journal: The Journal of adolescent health : official publication of the Society for Adolescent Medicine 20110101
Title: Long-term safety from the raltegravir clinical development program.
Journal: Current HIV research 20110101
Title: Renal disease associated with antiretroviral therapy in the treatment of HIV.
Journal: Nephron. Clinical practice 20110101
Title: Understanding diabetes in patients with HIV/AIDS.
Journal: Diabetology & metabolic syndrome 20110101
Title: Safety, Tolerability, and Efficacy of Second-Line Generic Protease Inhibitor Containing HAART after First-Line Failure among South Indian HIV-Infected Patients.
Journal: Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20110101
Title: Cost effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in treatment-naïve human immunodeficiency virus-infected patients in the United States.
Journal: Journal of medical economics 20110101
Title: Human immunodeficiency virus type 2 in two Saudi families.
Journal: Annals of Saudi medicine 20110101
Title: Chronic interstitial nephritis in an HIV type-1-infected patient receiving ritonavir-boosted atazanavir.
Journal: Antiviral therapy 20110101
Title: The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?
Journal: AIDS research and therapy 20110101
Title: Development of Buffalo Hump in the course of antiretroviral therapy including raltegravir and unboosted atazanavir: a case report and review of the literature.
Journal: Journal of medical case reports 20110101
Title: HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL.
Journal: Lipids in health and disease 20110101
Title: Management of HIV-1 associated hepatitis in patients with acquired immunodeficiency syndrome: role of a successful control of viral replication.
Journal: AIDS research and therapy 20110101
Title: Prevalence of potential drug-drug interactions involving antiretroviral drugs in a large Kenyan cohort.
Journal: PloS one 20110101
Title: Antiretroviral therapy outcomes in HIV-infected children after adjusting protease inhibitor dosing during tuberculosis treatment.
Journal: PloS one 20110101
Title: Time for gender mainstreaming in editorial policies.
Journal: Journal of the International AIDS Society 20110101
Title: Drug efficacy by direct and adjusted indirect comparison to placebo: An illustration by Mycobacterium avium complex prophylaxis in HIV.
Journal: AIDS research and therapy 20110101
Title: 'Dynamic range' of inferred phenotypic HIV drug resistance values in clinical practice.
Journal: PloS one 20110101
Title: Genome-wide analysis of primary CD4+ and CD8+ T cell transcriptomes shows evidence for a network of enriched pathways associated with HIV disease.
Journal: Retrovirology 20110101
Title: Acute toxicity of second generation HIV protease-inhibitors in combination with radiotherapy: a retrospective case series.
Journal: Radiation oncology (London, England) 20110101
Title: In vitro and in vivo cleavage of HIV-1 RNA by new SOFA-HDV ribozymes and their potential to inhibit viral replication.
Journal: RNA biology 20110101
Title: High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia.
Journal: Journal of the International AIDS Society 20110101
Title: The effect of atazanavir/ritonavir on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy women.
Journal: Antiviral therapy 20110101
Title: Interaction between antiretroviral drugs and acenocoumarol.
Journal: Antiviral therapy 20110101
Title: Machine learning on normalized protein sequences.
Journal: BMC research notes 20110101
Title: Comparison of intima-media thickness and ophthalmic artery resistance index for assessing subclinical atherosclerosis in HIV-1-infected patients.
Journal: Cardiovascular ultrasound 20110101
Title: Changes in lipid profiles after switching to a protease inhibitor-containing cART--unfavourable effect of fosamprenavir in obese patients.
Journal: European journal of medical research 20110101
Title: Open-label randomized multicenter selection study of once daily antiretroviral treatment regimen comparing ritonavir-boosted atazanavir to efavirenz with fixed-dose abacavir and lamivudine.
Journal: Internal medicine (Tokyo, Japan) 20110101
Title: The rainbow cohort: 96 week follow-up of saquinavir-containing regimens in previously antiretroviral therapy (ART)-naive and pre-treated but protease inhibitor (PI)-naive HIV-infected patients.
Journal: European journal of medical research 20110101
Title: Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings.
Journal: AIDS research and treatment 20110101
Title: Utilization patterns and projected demand of antiretroviral drugs in low- and middle-income countries.
Journal: AIDS research and treatment 20110101
Title: Protease Inhibitor Resistance Is Uncommon in HIV-1 Subtype C Infected Patients on Failing Second-Line Lopinavir/r-Containing Antiretroviral Therapy in South Africa.
Journal: AIDS research and treatment 20110101
Title: Ixabepilone as monotherapy or in combination with capecitabine for the treatment of advanced breast cancer.
Journal: Breast cancer : basic and clinical research 20110101
Title: Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN Trial.
Journal: Antiviral therapy 20110101
Title: Added value of deep sequencing relative to population sequencing in heavily pre-treated HIV-1-infected subjects.
Journal: PloS one 20110101
Title: HIV Protease Inhibitors: Effect on the Opportunistic Protozoan Parasites.
Journal: The open medicinal chemistry journal 20110101
Title: Contraception in HIV-positive female adolescents.
Journal: AIDS research and therapy 20110101
Title: A Multicenter, Open Labeled, Randomized, Phase III Study Comparing Lopinavir/Ritonavir Plus Atazanavir to Lopinavir/Ritonavir Plus Zidovudine and Lamivudine in Naive HIV-1-Infected Patients: 48-Week Analysis of the LORAN Trial.
Journal: The open AIDS journal 20110101
Title: HIV and HAART-Associated Dyslipidemia.
Journal: The open cardiovascular medicine journal 20110101
Title: Antiretroviral medications disrupt microglial phagocytosis of β-amyloid and increase its production by neurons: implications for HIV-associated neurocognitive disorders.
Journal: Molecular brain 20110101
Title: Breast Cancer in the Setting of HIV.
Journal: Pathology research international 20110101
Title: Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database.
Journal: PloS one 20110101
Title: Treatment durability, effectiveness, and safety with atazanavir/ritonavir-based HAART regimen in treatment-naïve HIV-infected patients.
Journal: HIV clinical trials 20110101
Title: Pharmacokinetics of switching unboosted atazanavir coadministered with tenofovir disoproxil fumarate from 400 mg once daily to 200 mg twice daily in HIV-positive patients.
Journal: Antiviral therapy 20110101
Title: Patterns of resistance development with integrase inhibitors in HIV.
Journal: Infection and drug resistance 20110101
Title: Blood Loss through AV Fistula: A Case Report and Literature Review.
Journal: International journal of nephrology 20110101
Title: Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy.
Journal: PloS one 20110101
Title: Atazanavir in children.
Journal: Prescrire international 20110101
Title: Reappearance of minority K103N HIV-1 variants after interruption of ART initiated during primary HIV-1 infection.
Journal: PloS one 20110101
Title: Does HAART efficacy translate to effectiveness? Evidence for a trial effect.
Journal: PloS one 20110101
Title: Genital lesions: An indication for changing ART regimen.
Journal: Indian journal of sexually transmitted diseases and AIDS 20110101
Title: Impact of small body weight on tenofovir-associated renal dysfunction in HIV-infected patients: a retrospective cohort study of Japanese patients.
Journal: PloS one 20110101
Title: Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis.
Journal: PloS one 20110101
Title: [Evidence-based therapeutic drug monitoring of atazanavir].
Journal: Therapie 20110101
Title: Treatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costs.
Journal: Patient preference and adherence 20110101
Title: Nephrotoxicity of HAART.
Journal: AIDS research and treatment 20110101
Title: HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat.
Journal: Retrovirology 20110101
Title: HIV drug resistance (HIVDR) in antiretroviral therapy-naïve patients in Tanzania not eligible for WHO threshold HIVDR survey is dramatically high.
Journal: PloS one 20110101
Title: Polymorphism in Gag gene cleavage sites of HIV-1 non-B subtype and virological outcome of a first-line lopinavir/ritonavir single drug regimen.
Journal: PloS one 20110101
Title: HIV protease inhibitors act as competitive inhibitors of the cytoplasmic glucose binding site of GLUTs with differing affinities for GLUT1 and GLUT4.
Journal: PloS one 20110101
Title: Protease inhibitors as preferred initial regimen for antiretroviral-naive HIV patients.
Journal: AIDS reviews 20110101
Title: Successful tacrolimus treatment following renal transplant in a HIV-infected patient with raltegravir previously treated with a protease inhibitor based regimen.
Journal: Drug metabolism and drug interactions 20110101
Title: A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries.
Journal: Globalization and health 20110101
Title: Prevalence and risk factors associated to chronic kidney disease in HIV-infected patients on HAART and undetectable viral load in Brazil.
Journal: PloS one 20110101
Title: Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellitus.
Journal: Journal of pharmacology & pharmacotherapeutics 20110101
Title: South Asian Consensus Guidelines for the rational management of diabetes in human immunodeficiency virus/acquired immunodeficiency syndrome.
Journal: Indian journal of endocrinology and metabolism 20110101
Title: Choosing a gliptin.
Journal: Indian journal of endocrinology and metabolism 20110101
Title: Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy.
Journal: BMC infectious diseases 20110101
Title: Impact of comorbidities and drug therapy on development of renal impairment in a predominantly African American and Hispanic HIV clinic population.
Journal: HIV/AIDS (Auckland, N.Z.) 20110101
Title: Characteristics of foot fractures in HIV-infected patients previously treated with tenofovir versus non-tenofovir-containing highly active antiretroviral therapy.
Journal: HIV/AIDS (Auckland, N.Z.) 20110101
Title: Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy.
Journal: HIV/AIDS (Auckland, N.Z.) 20110101
Title: Role of raltegravir in the management of HIV-1 infection.
Journal: HIV/AIDS (Auckland, N.Z.) 20110101
Title: AtriplaR/anti-TB combination in TB/HIV patients. Drug in focus.
Journal: BMC research notes 20110101
Title: Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy.
Journal: Retrovirology 20110101
Title: Effects of human immunodeficiency virus and metabolic complications on myocardial nutrient metabolism, blood flow, and oxygen consumption: a cross-sectional analysis.
Journal: Cardiovascular diabetology 20110101
Title: A system out of breath: how hypoxia possibly contributes to the pathogenesis of systemic sclerosis.
Journal: International journal of rheumatology 20110101
Title: Cost-effectiveness analysis of initial HIV treatment under Italian guidelines.
Journal: ClinicoEconomics and outcomes research : CEOR 20110101
Title: A multifaceted analysis of HIV-1 protease multidrug resistance phenotypes.
Journal: BMC bioinformatics 20110101
Title: Prevalence and impact of minority variant drug resistance mutations in primary HIV-1 infection.
Journal: PloS one 20110101
Title: Critical appraisal of ticagrelor in the management of acute coronary syndrome.
Journal: Therapeutics and clinical risk management 20110101
Title: Twice-daily versus once-daily antiretroviral therapy and coformulation strategies in HIV-infected adults: benefits, risks, or burden?
Journal: Patient preference and adherence 20110101
Title: Comparative manufacture and cell-based delivery of antiretroviral nanoformulations.
Journal: International journal of nanomedicine 20110101
Title: High FDG uptake on FDG-PET scan in HIV-1 infected patient with advanced disease.
Journal: Acta clinica Belgica 20110101
Title: Clinical Use of Inhibitors of HIV-1 Integration: Problems and Prospects.
Journal: Acta naturae 20110101
Title: Nanoformulated antiretroviral drug combinations extend drug release and antiretroviral responses in HIV-1-infected macrophages: implications for neuroAIDS therapeutics.
Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 20101201
Title: Exposure-related effects of atazanavir on the pharmacokinetics of raltegravir in HIV-1-infected patients.
Journal: Therapeutic drug monitoring 20101201
Title: Analysis of mixed stones is prone to error: a study with US laboratories using micro CT for verification of sample content.
Journal: Urological research 20101201
Title: Interview with Dr. Mark Cockett: current trends in screening for antiviral therapeutics. Interviewed by Nina N. Brahme and Devin J. Noblin.
Journal: The Yale journal of biology and medicine 20101201
Title: Impact of atazanavir-based HAART regimen on the carotid intima-media thickness of HIV-infected persons: a comparative prospective cohort.
Journal: AIDS (London, England) 20101127
Title: Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patients.
Journal: HIV medicine 20101101
Title: Comparison of two HIV postexposure prophylaxis regimens among men who have sex with men in Amsterdam: adverse effects do not influence compliance.
Journal: Sexually transmitted diseases 20101101
Title: Outcomes of patients on dual-boosted PI regimens: experience of the Swiss HIV cohort study.
Journal: AIDS research and human retroviruses 20101101
Title: Broadening the perspective when assessing evidence on boosted protease inhibitor-based regimens for initial antiretroviral therapy.
Journal: Advances in therapy 20101101
Title: HIV-1 induces DCIR expression in CD4+ T cells.
Journal: PLoS pathogens 20101101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20101101
Title: Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs.
Journal: Viruses 20101101
Title: Molecular Basis for Drug Resistance in HIV-1 Protease.
Journal: Viruses 20101101
Title: Effect of simplification from protease inhibitors to boosted atazanavir-based regimens in real-life conditions.
Journal: HIV medicine 20101001
Title: Inaccurate reporting of mineral composition by commercial stone analysis laboratories: implications for infection and metabolic stones.
Journal: The Journal of urology 20101001
Title: Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20101001
Title: Incidence of atazanavir-associated hyperbilirubinemia in Korean HIV patients: 30 months follow-up results in a population with low UDP-glucuronosyltransferase1A1*28 allele frequency.
Journal: Journal of Korean medical science 20101001
Title: Recent FDA approvals and changes.
Journal: AIDS patient care and STDs 20101001
Title: An efficient HPLC method for the quantitative determination of atazanavir in human plasma suitable for bioequivalence and pharmacokinetic studies in healthy human subjects.
Journal: Journal of pharmaceutical and biomedical analysis 20100921
Title: Immunodeficiency and renal impairment are risk factors for HIV-associated acute renal failure.
Journal: AIDS (London, England) 20100910
Title: HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions.
Journal: Journal of pharmaceutical and biomedical analysis 20100905
Title: pH dependence of organic anion-transporting polypeptide 2B1 in Caco-2 cells: potential role in antiretroviral drug oral bioavailability and drug-drug interactions.
Journal: The Journal of pharmacology and experimental therapeutics 20100901
Title: Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir/ritonavir: systematic review and meta-analysis of randomized controlled trials.
Journal: The Journal of antimicrobial chemotherapy 20100901
Title: KI and WU polyomaviruses and CD4+ cell counts in HIV-1-infected patients, Italy.
Journal: Emerging infectious diseases 20100901
Title: Similar efficacy and tolerability of atazanavir compared with atazanavir/ritonavir, each with abacavir/lamivudine after initial suppression with abacavir/lamivudine plus ritonavir-boosted atazanavir in HIV-infected patients.
Journal: AIDS (London, England) 20100824
Title: Novel protease inhibitors (PIs) containing macrocyclic components and 3(R),3a(S),6a(R)-bis-tetrahydrofuranylurethane that are potent against multi-PI-resistant HIV-1 variants in vitro.
Journal: Antimicrobial agents and chemotherapy 20100801
Title: A less sensitive detector does not necessarily result in a less sensitive method: fast quantification of 13 antiretroviral analytes in plasma with liquid chromatography coupled with tandem mass spectrometry.
Journal: Clinical chemistry and laboratory medicine 20100801
Title: Methadone, buprenorphine, and street drug interactions with antiretroviral medications.
Journal: Current HIV/AIDS reports 20100801
Title: Protease inhibitors atazanavir, lopinavir and ritonavir are potent blockers, but poor substrates, of ABC transporters in a broad panel of ABC transporter-overexpressing cell lines.
Journal: The Journal of antimicrobial chemotherapy 20100801
Title: Drug-drug interaction profiles of proton pump inhibitors.
Journal: Clinical pharmacokinetics 20100801
Title: Cardiovascular risk evaluation and antiretroviral therapy effects in an HIV cohort: implications for clinical management: the CREATE 1 study.
Journal: International journal of clinical practice 20100801
Title: Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity.
Journal: Toxins 20100801
Title: Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.
Journal: AIDS (London, England) 20100717
Title: Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment.
Journal: Journal of urban health : bulletin of the New York Academy of Medicine 20100701
Title: Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA.
Journal: The Journal of infectious diseases 20100701
Title: Genetic factors influencing severe atazanavir-associated hyperbilirubinemia in a population with low UDP-glucuronosyltransferase 1A1*28 allele frequency.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100701
Title: Role of Gag in HIV Resistance to Protease Inhibitors.
Journal: Viruses 20100701
Title: Resveratrol protects against protease inhibitor-induced reactive oxygen species production, reticulum stress and lipid raft perturbation.
Journal: AIDS (London, England) 20100619
Title: Factors predictive of virological failure on atazanavir in 310 HIV-infected patients.
Journal: AIDS (London, England) 20100619
Title: Species-specific interaction of HIV protease inhibitors with accumulation of cholyl-glycylamido-fluorescein (CGamF) in sandwich-cultured hepatocytes.
Journal: Journal of pharmaceutical sciences 20100601
Title: Validation of a rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for the simultaneous determination of existing and new antiretroviral compounds.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100601
Title: Gastrointestinal tolerability and quality of life in antiretroviral-naive HIV-1-infected patients: data from the CASTLE study.
Journal: AIDS care 20100601
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20100601
Title: Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir.
Journal: AIDS (London, England) 20100515
Title: Mass spectrometry and renal calculi.
Journal: Journal of medicine and life 20100515
Title: Mid-dosing interval concentration of atazanavir and virological outcome in patients treated for HIV-1 infection.
Journal: HIV medicine 20100501
Title: HIV-protease inhibitors suppress skeletal muscle fatty acid oxidation by reducing CD36 and CPT1 fatty acid transporters.
Journal: Biochimica et biophysica acta 20100501
Title: Assessment of the susceptibility of mutant HIV-1 to antiviral agents.
Journal: Journal of virological methods 20100501
Title: Effect of ritonavir and atazanavir on human subcutaneous preadipocyte proliferation and differentiation.
Journal: Antiviral research 20100501
Title: Concentration-dependent effects and intracellular accumulation of HIV protease inhibitors in cultured CD4 T cells and primary human lymphocytes.
Journal: The Journal of antimicrobial chemotherapy 20100501
Title: Evaluating the substrate-envelope hypothesis: structural analysis of novel HIV-1 protease inhibitors designed to be robust against drug resistance.
Journal: Journal of virology 20100501
Title: Efficacy and safety of unboosted atazanavir in combination with lamivudine and didanosine in naive HIV type 1 patients in Senegal.
Journal: AIDS research and human retroviruses 20100501
Title: Differential effects of efavirenz, lopinavir/r, and atazanavir/r on the initial viral decay rate in treatment naïve HIV-1-infected patients.
Journal: AIDS research and human retroviruses 20100501
Title: Special issue: retroviral enzymes.
Journal: Viruses 20100501
Title: [Protease inhibitor or non-nucleoside reverse transcriptase inhibitor. ACTG study 5202 in focus].
Journal: MMW Fortschritte der Medizin 20100429
Title: The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naïve HIV-1 infected patients.
Journal: European journal of clinical pharmacology 20100401
Title: Atazanavir plasma concentrations are impaired in HIV-1-infected adults simultaneously taking a methadone oral solution in a once-daily observed therapy setting.
Journal: European journal of clinical pharmacology 20100401
Title: Identification of proteasome gene regulation in a rat model for HIV protease inhibitor-induced hyperlipidemia.
Journal: Archives of toxicology 20100401
Title: Impact of low abundance HIV variants on response to ritonavir-boosted atazanavir or fosamprenavir given once daily with tenofovir/emtricitabine in antiretroviral-naive HIV-infected patients.
Journal: AIDS research and human retroviruses 20100401
Title: Analysis of the effects of specific protease inhibitors on OPG/RANKL regulation in an osteoblast-like cell line.
Journal: The new microbiologica 20100401
Title: Change to atazanavir/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapy.
Journal: AIDS (London, England) 20100327
Title: Trends in uptake of recently approved antiretrovirals within a national healthcare system.
Journal: HIV medicine 20100301
Title: Once-daily atazanavir/ritonavir compared with twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 96-week efficacy and safety results of the CASTLE study.
Journal: Journal of acquired immune deficiency syndromes (1999) 20100301
Title: Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1.
Journal: Xenobiotica; the fate of foreign compounds in biological systems 20100301
Title: Single-tablet Quad regimen achieves high rate of virologic suppression.
Journal: AIDS patient care and STDs 20100301
Title: Interaction of eight HIV protease inhibitors with the canalicular efflux transporter ABCC2 (MRP2) in sandwich-cultured rat and human hepatocytes.
Journal: Biopharmaceutics & drug disposition 20100301
Title: Rapid UGT1A1 (TA)(n) genotyping by high resolution melting curve analysis for Gilbert's syndrome diagnosis.
Journal: Clinica chimica acta; international journal of clinical chemistry 20100201
Title: Synthesis and biological evaluation of novel allophenylnorstatine-based HIV-1 protease inhibitors incorporating high affinity P2-ligands.
Journal: Bioorganic & medicinal chemistry letters 20100201
Title: HIV protease inhibitors block oral epithelial cell DNA synthesis.
Journal: Archives of oral biology 20100201
Title: Effect of nevirapine on the steady-state trough concentrations of atazanavir in HIV-infected patients receiving atazanavir/ritonavir.
Journal: Therapeutic drug monitoring 20100201
Title: HIV-1 protease inhibitors with a transition-state mimic comprising a tertiary alcohol: improved antiviral activity in cells.
Journal: Journal of medicinal chemistry 20100128
Title: Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008.
Journal: Archives of internal medicine 20100111
Title: Efficacy and safety of boosted and unboosted atazanavir-containing antiretroviral regimens in real life: results from a multicentre cohort study.
Journal: HIV medicine 20100101
Title: Pharmacogenetics of antiretrovirals.
Journal: Antiviral research 20100101
Title: Factors influencing lopinavir and atazanavir plasma concentration.
Journal: The Journal of antimicrobial chemotherapy 20100101
Title: Analysis of CYP3A4-HIV-1 protease drugs interactions by computational methods for Highly Active Antiretroviral Therapy in HIV/AIDS.
Journal: Journal of molecular graphics & modelling 20100101
Title: Atazanavir-associated choledocholithiasis leading to acute hepatitis in an HIV-infected adult.
Journal: The Annals of pharmacotherapy 20100101
Title: The cost and incidence of prescribing errors among privately insured HIV patients.
Journal: PharmacoEconomics 20100101
Title: 96-week efficacy and safety of atazanavir, with and without ritonavir, in a HAART regimen in treatment-naive patients.
Journal: Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20100101
Title: Anticoagulant therapy for nodular regenerative hyperplasia in a HIV-infected patient.
Journal: BMC gastroenterology 20100101
Title: The mitochondria-independent cytotoxic effect of nelfinavir on leukemia cells can be enhanced by sorafenib-mediated mcl-1 downregulation and mitochondrial membrane destabilization.
Journal: Molecular cancer 20100101
Title: Towards a Patent Pool for HIV Medicines: The Background.
Journal: The open AIDS journal 20100101
Title: Patent Pooling for Promoting Access to Antiretroviral Drugs (ARVs) - A Strategic Option for India.
Journal: The open AIDS journal 20100101
Title: Berberine inhibits HIV protease inhibitor-induced inflammatory response by modulating ER stress signaling pathways in murine macrophages.
Journal: PloS one 20100101
Title: Pooling ARV Drug Patents: A Pro-Access Fitting Strategy?
Journal: The open AIDS journal 20100101
Title: Profile of etravirine for the treatment of HIV infection.
Journal: Therapeutics and clinical risk management 20100101
Title: Extracting causal relations on HIV drug resistance from literature.
Journal: BMC bioinformatics 20100101
Title: Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART study.
Journal: PloS one 20100101
Title: Designing ARVs Patent Pool Up to Trade & Policy Evolutionary Dynamics.
Journal: The open AIDS journal 20100101
Title: Impact of ritonavir, atazanavir and their combination on the CYP3A4 induction potential of efavirenz in primary human hepatocytes.
Journal: Drug metabolism letters 20100101
Title: Toxicokinetic interaction between quetiapine and antiretroviral therapy following quetiapine overdose.
Journal: Drug metabolism letters 20100101
Title: Decreased NK Cell FcRgamma in HIV-1 infected individuals receiving combination antiretroviral therapy: a cross sectional study.
Journal: PloS one 20100101
Title: Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy.
Journal: Retrovirology 20100101
Title: Abacavir/lamivudine combination in the treatment of HIV: a review.
Journal: Therapeutics and clinical risk management 20100101
Title: Raltegravir is a potent inhibitor of XMRV, a virus implicated in prostate cancer and chronic fatigue syndrome.
Journal: PloS one 20100101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20100101
Title: [Adverse reactions of atazanavir, fosamprenavir and tipranavir in 'real life'].
Journal: Therapie 20100101
Title: Semen may harbor HIV despite effective HAART: another piece in the puzzle.
Journal: PloS one 20100101
Title: HIV protease inhibitors activate the adipocyte renin angiotensin system.
Journal: Antiviral therapy 20100101
Title: Genotypic and phenotypic evolution of HIV type-1 protease during in vitro sequential or concomitant combination of atazanavir and amprenavir.
Journal: Antiviral therapy 20100101
Title: Gender differences in clinical, immunological, and virological outcomes in highly active antiretroviral-treated HIV-HCV coinfected patients.
Journal: Patient preference and adherence 20100101
Title: ICAAC update. Three new drugs in development, plus Isentress with Reyataz.
Journal: Positively aware : the monthly journal of the Test Positive Aware Network 20100101
Title: Dynamics of lamin-A processing following precursor accumulation.
Journal: PloS one 20100101
Title: An assay to monitor HIV-1 protease activity for the identification of novel inhibitors in T-cells.
Journal: PloS one 20100101
Title: Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naïve subjects in the CASTLE study.
Journal: PloS one 20100101
Title: Safety and efficacy of a 36-week induction regimen of abacavir/lamivudine and ritonavir-boosted atazanavir in HIV-infected patients.
Journal: HIV clinical trials 20100101
Title: Transmission of human immunodeficiency virus I drug resistance - a case report. What are the clinical implications?
Journal: European journal of medical research 20100101
Title: Co-lethality studied as an asset against viral drug escape: the HIV protease case.
Journal: Biology direct 20100101
Title: Pulmonary Embolism Mimicking Pneumonia in a HIV Patient.
Journal: Case reports in medicine 20100101
Title: Tamoxifen enhances the cytotoxic effects of nelfinavir in breast cancer cells.
Journal: Breast cancer research : BCR 20100101
Title: Development of a liposomal nanodelivery system for nevirapine.
Journal: Journal of biomedical science 20100101
Title: Ultra-fast analysis of plasma and intracellular levels of HIV protease inhibitors in children: a clinical application of MALDI mass spectrometry.
Journal: PloS one 20100101
Title: High performance liquid chromatography using UV detection for the simultaneous quantification of the new non-nucleoside reverse transcriptase inhibitor etravirine (TMC-125), and 4 protease inhibitors in human plasma.
Journal: Biological & pharmaceutical bulletin 20100101
Title: Evaluation of HIV protease and nucleoside reverse transcriptase inhibitors on proliferation, necrosis, apoptosis in intestinal epithelial cells and electrolyte and water transport and epithelial barrier function in mice.
Journal: BMC gastroenterology 20100101
Title: Simplified maintenance therapy with abacavir/lamivudine and atazanavir after discontinuation of ritonavir.
Journal: HIV clinical trials 20100101
Title: Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors.
Journal: Retrovirology 20100101
Title: Acquired Long QT Syndrome and Torsade de Pointes Associated with HIV Infection.
Journal: Case reports in medicine 20100101
Title: Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen.
Journal: Clinical epidemiology 20100101
Title: Comparative biochemical analysis of recombinant reverse transcriptase enzymes of HIV-1 subtype B and subtype C.
Journal: Retrovirology 20100101
Title: The bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in mice.
Journal: PloS one 20100101
Title: The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children.
Journal: BMC pediatrics 20100101
Title: Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patients.
Journal: European journal of medical research 20100101
Title: Progress in antiretroviral drug delivery using nanotechnology.
Journal: International journal of nanomedicine 20100101
Title: The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010.
Journal: BMC infectious diseases 20100101
Title: Unboosted atazanavir-based therapy maintains control of HIV type-1 replication as effectively as a ritonavir-boosted regimen.
Journal: Antiviral therapy 20100101
Title: Raltegravir and unboosted atazanavir dual therapy in virologically suppressed antiretroviral treatment-experienced HIV patients.
Journal: Antiviral therapy 20100101
Title: Saxagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus.
Journal: Core evidence 20100101
Title: Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based models.
Journal: PloS one 20100101
Title: Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections.
Journal: Drug design, development and therapy 20100101
Title: Pharmacokinetics and safety of twice-daily atazanavir 300 mg and raltegravir 400 mg in healthy individuals.
Journal: Antiviral therapy 20100101
Title: In vitro susceptibility and virological outcome to darunavir and lopinavir are independent of HIV type-1 subtype in treatment-naive patients.
Journal: Antiviral therapy 20100101
Title: Methods development for blood borne macrophage carriage of nanoformulated antiretroviral drugs.
Journal: Journal of visualized experiments : JoVE 20100101
Title: Torsade de Pointes due to Methadone Use in a Patient with HIV and Hepatitis C Coinfection.
Journal: Cardiology research and practice 20100101
Title: Saxagliptin for type 2 diabetes.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy 20100101
Title: Lipid Metabolism and Cardiovascular Risk in HIV-1 Infection and HAART: Present and Future Problems.
Journal: Cholesterol 20100101
Title: Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection.
Journal: Infection and drug resistance 20100101
Title: Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapy.
Journal: Infection and drug resistance 20100101
Title: Novel strategies in the use of lopinavir/ritonavir for the treatment of HIV infection in children.
Journal: HIV/AIDS (Auckland, N.Z.) 20100101
Title: Role of etravirine in the management of treatment-experienced patients with human immunodeficiency virus type 1.
Journal: HIV/AIDS (Auckland, N.Z.) 20100101
Title: Profile of maraviroc: a CCR5 antagonist in the management of treatment-experienced HIV patients.
Journal: HIV/AIDS (Auckland, N.Z.) 20100101
Title: Long-term treatment of patients with HIV-1: the role of atazanavir.
Journal: HIV/AIDS (Auckland, N.Z.) 20100101
Title: New and emerging agents in the management of lipodystrophy in HIV-infected patients.
Journal: HIV/AIDS (Auckland, N.Z.) 20100101
Title: Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor.
Journal: Journal of blood medicine 20100101
Title: Validation of an electrospray ionization LC-MS/MS method for quantitative analysis of raltegravir, etravirine, and 9 other antiretroviral agents in human plasma samples.
Journal: Therapeutic drug monitoring 20091201
Title: Antiretroviral genotypic resistance mutations in HIV-1 infected Korean patients with virologic failure.
Journal: Journal of Korean medical science 20091201
Title: HIV-1 Protease: Structural Perspectives on Drug Resistance.
Journal: Viruses 20091201
Title: Current and Novel Inhibitors of HIV Protease.
Journal: Viruses 20091201
Title: How much ritonavir is needed to boost protease inhibitors? Systematic review of 17 dose-ranging pharmacokinetic trials.
Journal: AIDS (London, England) 20091113
Title: Effect of serum lipids on the pharmacokinetics of atazanavir in hyperlipidemic rats.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20091101
Title: Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors.
Journal: The Journal of antimicrobial chemotherapy 20091101
Title: Efavirenz: a decade of clinical experience in the treatment of HIV.
Journal: The Journal of antimicrobial chemotherapy 20091101
Title: Clinically significant adverse events from a drug interaction between quetiapine and atazanavir-ritonavir in two patients.
Journal: Pharmacotherapy 20091101
Title: Tenofovir coadministration is not associated with lower unboosted atazanavir plasma exposure in the clinical setting.
Journal: Journal of acquired immune deficiency syndromes (1999) 20091101
Title: Clinical pharmacology, efficacy and safety of atazanavir: a review.
Journal: Expert opinion on drug metabolism & toxicology 20091101
Title: Transplacental transfer of antiretroviral drugs and newborn birth weight in HIV-infected pregnant women.
Journal: Current HIV research 20091101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20091101
Title: Lithiasis of semicircular canals and parotid glands: unusual stones deposition in atazanavir-treated individuals.
Journal: AIDS (London, England) 20091023
Title: Atazanavir-related renal insufficiency without concurrent tenofovir.
Journal: Enfermedades infecciosas y microbiologia clinica 20091001
Title: A liquid chromatography-tandem mass spectrometry assay for quantification of nevirapine, indinavir, atazanavir, amprenavir, saquinavir, ritonavir, lopinavir, efavirenz, tipranavir, darunavir and maraviroc in the plasma of patients infected with HIV.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20091001
Title: The nephrotoxic effects of HAART.
Journal: Nature reviews. Nephrology 20091001
Title: Response to Crum-Cianflone et al., syphilitic hepatitis among HIV-infected patients.
Journal: International journal of STD & AIDS 20091001
Title: Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal.
Journal: PLoS medicine 20091001
Title: Report from the 5th IAS Conference on HIV Pathogenesis Treatment and Prevention. Nevirapine vs. boosted atazanavir--the ARTEN Study.
Journal: Journal watch. AIDS clinical care 20091001
Title: [Iatrogenic Cushing's syndrome, diabetes mellitus and secondary adrenal failure in a human immunodeficiency virus patient treated with ritonavir boosted atazanavir and fluticasone].
Journal: Annales d'endocrinologie 20090901
Title: Identification and profiling of circulating metabolites of atazanavir, a HIV protease inhibitor.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20090901
Title: New developments in HIV drug resistance.
Journal: The Journal of antimicrobial chemotherapy 20090901
Title: The history of antiretrovirals: key discoveries over the past 25 years.
Journal: Reviews in medical virology 20090901
Title: Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders.
Journal: Journal of acquired immune deficiency syndromes (1999) 20090901
Title: The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients.
Journal: Expert review of anti-infective therapy 20090901
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20090901
Title: Human immunodeficiency virus: 25 years of diagnostic and therapeutic strategies and their impact on hepatitis B and C virus.
Journal: Medical microbiology and immunology 20090801
Title: Effects of oral posaconazole on the pharmacokinetics of atazanavir alone and with ritonavir or with efavirenz in healthy adult volunteers.
Journal: Journal of acquired immune deficiency syndromes (1999) 20090801
Title: Pharmacokinetics of concurrent administration of fosamprenavir and atazanavir without ritonavir in human immunodeficiency virus-negative subjects.
Journal: Pharmacotherapy 20090801
Title: Effects of switching from lopinavir/ritonavir to atazanavir/ritonavir on muscle glucose uptake and visceral fat in HIV-infected patients.
Journal: AIDS (London, England) 20090717
Title: A combination drug of abacavir-lamivudine-zidovudine (Trizivir) for treating HIV infection and AIDS.
Journal: The Cochrane database of systematic reviews 20090708
Title: Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study.
Journal: The Journal of antimicrobial chemotherapy 20090701
Title: HIV protease inhibitors: recent clinical trials and recommendations on use.
Journal: Expert opinion on pharmacotherapy 20090701
Title: Molecular dynamics and free energy studies on the wild-type and mutated HIV-1 protease complexed with four approved drugs: mechanism of binding and drug resistance.
Journal: Journal of chemical information and modeling 20090701
Title: Systematic review: impaired drug absorption related to the co-administration of antisecretory therapy.
Journal: Alimentary pharmacology & therapeutics 20090615
Title: Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy.
Journal: Journal of clinical epidemiology 20090601
Title: Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patients.
Journal: Infection 20090601
Title: Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers.
Journal: The Journal of antimicrobial chemotherapy 20090601
Title: Improvement in lipid profiles in antiretroviral-experienced HIV-positive patients with hyperlipidemia after a switch to unboosted atazanavir.
Journal: Journal of acquired immune deficiency syndromes (1999) 20090601
Title: Case report: clearance of hepatitis C virus after changing the HAART regimen in a patient infected with hepatitis C virus and the human immunodeficiency virus.
Journal: Journal of medical virology 20090601
Title: Neuropsychological assessment of HIV-infected populations in international settings.
Journal: Neuropsychology review 20090601
Title: Efficacy and safety of atazanavir in patients with end-stage liver disease.
Journal: Infection 20090601
Title: Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts.
Journal: Infection 20090601
Title: Atazanavir: new indication. First-line treatment: fewer gastrointestinal disorders but more cases of jaundice and a risk of torsades de pointes.
Journal: Prescrire international 20090601
Title: Atazanavir: a review of its use in the management of HIV-1 infection.
Journal: Drugs 20090529
Title: Interactions of different inhibitors with active-site aspartyl residues of HIV-1 protease and possible relevance to pepsin.
Journal: Proteins 20090515
Title: Role of cell signaling in poxvirus-mediated foreign gene expression in mammalian cells.
Journal: Vaccine 20090514
Title: Effects of ritonavir-boosted darunavir vs. ritonavir-boosted atazanavir on lipid and glucose parameters in HIV-negative, healthy volunteers.
Journal: HIV medicine 20090501
Title: Changes in body composition with ritonavir-boosted and unboosted atazanavir treatment in combination with Lamivudine and Stavudine: a 96-week randomized, controlled study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090501
Title: Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP study.
Journal: Journal of acquired immune deficiency syndromes (1999) 20090501
Title: Provider prescribing of 4 antiretroviral agents after implementation of drug use guidelines in the Department of Veterans Affairs.
Journal: Journal of managed care pharmacy : JMCP 20090501
Title: Rhabdomyolysis in an HIV-infected patient on anti-retroviral therapy precipitated by high-dose pravastatin.
Journal: Current drug safety 20090501
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20090501
Title: [Medication change due to side effects or possible long-term complications. Side effect management with vision].
Journal: MMW Fortschritte der Medizin 20090430
Title: 2-Pyridyl P1'-substituted symmetry-based human immunodeficiency virus protease inhibitors (A-792611 and A-790742) with potential for convenient dosing and reduced side effects.
Journal: Journal of medicinal chemistry 20090423
Title: Etravirine, a next-generation nonnucleoside reverse-transcriptase inhibitor.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090415
Title: Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV.
Journal: International journal of antimicrobial agents 20090401
Title: A low dose of ritonavir-boosted atazanavir provides adequate pharmacokinetic parameters in HIV-1-infected Thai adults.
Journal: Clinical pharmacology and therapeutics 20090401
Title: Protease inhibitors used in the treatment of HIV+ induce beta-cell apoptosis via the mitochondrial pathway and compromise insulin secretion.
Journal: American journal of physiology. Endocrinology and metabolism 20090401
Title: HIV-1 protease inhibitor induced oxidative stress suppresses glucose stimulated insulin release: protection with thymoquinone.
Journal: Experimental biology and medicine (Maywood, N.J.) 20090401
Title: Select updates from the 16th CROI: treatment-related cardiovascular risk, pharmacokinetic issues, and interleukin-2 use.
Journal: The AIDS reader 20090401
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20090401
Title: Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes.
Journal: The Journal of infectious diseases 20090315
Title: Effect of atazanavir versus other protease inhibitor-containing antiretroviral therapy on endothelial function in HIV-infected persons: randomised controlled trial.
Journal: Heart (British Cardiac Society) 20090301
Title: Up-regulation of P-glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line.
Journal: Journal of neuroscience research 20090301
Title: GRL-02031, a novel nonpeptidic protease inhibitor (PI) containing a stereochemically defined fused cyclopentanyltetrahydrofuran potent against multi-PI-resistant human immunodeficiency virus type 1 in vitro.
Journal: Antimicrobial agents and chemotherapy 20090301
Title: Maintaining reduced viral fitness and CD4 response in HIV-infected patients with viremia receiving a boosted protease inhibitor.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090301
Title: Hepatotoxicity and gastrointestinal intolerance when healthy volunteers taking rifampin add twice-daily atazanavir and ritonavir.
Journal: Journal of acquired immune deficiency syndromes (1999) 20090301
Title: Gag mutations strongly contribute to HIV-1 resistance to protease inhibitors in highly drug-experienced patients besides compensating for fitness loss.
Journal: PLoS pathogens 20090301
Title: Protease inhibitor levels in hair strongly predict virologic response to treatment.
Journal: AIDS (London, England) 20090220
Title: Quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in peripheral blood mononuclear cell lysate using liquid chromatography coupled with tandem mass spectrometry.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090215
Title: Warfarin-antiretroviral interactions.
Journal: The Annals of pharmacotherapy 20090201
Title: Cost-effectiveness analysis of lopinavir/ritonavir and atazanavir+ritonavir regimens in the CASTLE study.
Journal: Advances in therapy 20090201
Title: [Atazanavir-induced nephrolithiasis].
Journal: Enfermedades infecciosas y microbiologia clinica 20090201
Title: HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review.
Journal: AIDS (London, England) 20090128
Title: Low atazanavir concentrations in cerebrospinal fluid.
Journal: AIDS (London, England) 20090102
Title: Extension of the SAEM algorithm for nonlinear mixed models with 2 levels of random effects.
Journal: Biostatistics (Oxford, England) 20090101
Title: Quantification of 8 HIV-protease inhibitors and 2 nonnucleoside reverse transcriptase inhibitors by ultra-performance liquid chromatography with diode array detection.
Journal: Clinical chemistry 20090101
Title: Antiretroviral-related adipocyte dysfunction and lipodystrophy in HIV-infected patients: Alteration of the PPARγ-dependent pathways.
Journal: PPAR research 20090101
Title: Survey of physician knowledge regarding antiretroviral medications in hospitalized HIV-infected patients.
Journal: Journal of the International AIDS Society 20090101
Title: Top stories of 2008. Beyond abacavir/3TC: good news on first-line regimens.
Journal: AIDS clinical care 20090101
Title: Comparison of Markov model and discrete-event simulation techniques for HIV.
Journal: PharmacoEconomics 20090101
Title: Raltegravir with unboosted atazanavir 300 mg twice daily in antiretroviral treatment-experienced participants.
Journal: Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20090101
Title: A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327, the ACTION Study).
Journal: AIDS research and therapy 20090101
Title: Role of atazanavir in the treatment of HIV infection.
Journal: Therapeutics and clinical risk management 20090101
Title: Emtricitabine/tenofovir disoproxil fumarate: in combination with a protease inhibitor in HIV-1 infection.
Journal: Drugs 20090101
Title: Adrenal suppression due to an interaction between ritonavir and injected triamcinolone: a case report.
Journal: AIDS research and therapy 20090101
Title: Emerging role of integrase inhibitors in the management of treatment-experienced patients with HIV infection.
Journal: Therapeutics and clinical risk management 20090101
Title: Serum lipid profiles among patients initiating ritonavir-boosted atazanavir versus efavirenz-based regimens.
Journal: AIDS research and therapy 20090101
Title: Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use.
Journal: PloS one 20090101
Title: Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection.
Journal: PloS one 20090101
Title: Differences in resistance mutations among HIV-1 non-subtype B infections: a systematic review of evidence (1996-2008).
Journal: Journal of the International AIDS Society 20090101
Title: Anti-HIV agents. Atazanavir and raltegravir--an interesting combination.
Journal: TreatmentUpdate 20090101
Title: Host sequence motifs shared by HIV predict response to antiretroviral therapy.
Journal: BMC medical genomics 20090101
Title: Unboosted atazanavir plus co-formulated lamivudine/abacavir as a ritonavir-sparing simplification strategy in routine clinical practice.
Journal: HIV clinical trials 20090101
Title: Occurrence of selective ritonavir nonadherence and dose-staggering in recipients of boosted HIV-1 protease inhibitor therapy.
Journal: HIV clinical trials 20090101
Title: Baseline lipid levels rather than the presence of reported body shape changes determine the degree of improvement in lipid levels after switching to atazanavir.
Journal: HIV clinical trials 20090101
Title: Novel methodology for antiretroviral quantitation in the female genital tract.
Journal: HIV clinical trials 20090101
Title: The Impact of HIV and Malaria Coinfection: What Is Known and Suggested Venues for Further Study.
Journal: Interdisciplinary perspectives on infectious diseases 20090101
Title: Pharmacotherapy of pediatric and adolescent HIV infection.
Journal: Therapeutics and clinical risk management 20090101
Title: Managing treatment-experienced pediatric and adolescent HIV patients: role of darunavir.
Journal: Therapeutics and clinical risk management 20090101
Title: HIV-associated bladder cancer: a case series evaluating difficulties in diagnosis and management.
Journal: BMC urology 20090101
Title: Short-term effect of ritonavir-boosted atazanavir in hepatitis B and/or C co-infected, treatment-experienced HIV patients.
Journal: HIV clinical trials 20090101
Title: Impact of first-line protease inhibitors on predicted resistance to tipranavir in HIV-1-infected patients with virological failure.
Journal: BMC infectious diseases 20090101
Title: Pairwise and higher-order correlations among drug-resistance mutations in HIV-1 subtype B protease.
Journal: BMC bioinformatics 20090101
Title: Comparison of 3-drug versus 4-drug and PI versus non-PI combinations as initial HAART: experience from 1998 to 2007.
Journal: Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20090101
Title: Drugs associated with more suicidal ideations are also associated with more suicide attempts.
Journal: PloS one 20090101
Title: XVII International AIDS Conference: From Evidence to Action - Clinical and biomedical prevention science.
Journal: Journal of the International AIDS Society 20090101
Title: High molecular weight form of adiponectin in antiretroviral drug-induced dyslipidemia in HIV-infected Japanese individuals based on in vivo and in vitro analyses.
Journal: Internal medicine (Tokyo, Japan) 20090101
Title: Oxidative imbalance in HIV-1 infected patients treated with antiretroviral therapy.
Journal: Journal of biomedicine & biotechnology 20090101
Title: Electrocardiogram abnormalities with atazanavir and lopinavir/ritonavir.
Journal: HIV clinical trials 20090101
Title: P-glycoprotein, multidrug resistance-associated proteins and human organic anion transporting polypeptide influence the intracellular accumulation of atazanavir.
Journal: Antiviral therapy 20090101
Title: Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib.
Journal: Drug design, development and therapy 20090101
Title: Algorithms for the assessment and management of insomnia in primary care.
Journal: Patient preference and adherence 20090101
Title: First-line boosted protease inhibitor-based regimens in treatment-naive HIV-1-infected patients--making a good thing better.
Journal: AIDS reviews 20090101
Title: The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review.
Journal: BMC public health 20090101
Title: Correlations between atazanavir C(trough )and hyperbilirubinemia: a case report.
Journal: Journal of medical case reports 20090101
Title: Severe skin rash associated with atazanavir.
Journal: The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale 20090101
Title: Raltegravir: The evidence of its therapeutic value in HIV-1 infection.
Journal: Core evidence 20090101
Title: Etravirine (TMC-125): The evidence for its place in the treatment of HIV-1 infection.
Journal: Core evidence 20090101
Title: Rapid and persistent selection of the K103N mutation as a majority quasispecies in a HIV1-patient exposed to efavirenz for three weeks: a case report and review of the literature.
Journal: Journal of medical case reports 20090101
Title: New approaches in the management of chronic hepatitis B: role of tenofovir.
Journal: Infection and drug resistance 20090101
Title: Role of darunavir in the management of HIV infection.
Journal: HIV/AIDS (Auckland, N.Z.) 20090101
Title: The effect of atazanavir and atazanavir/ritonavir on UDP-glucuronosyltransferase using lamotrigine as a phenotypic probe.
Journal: Clinical pharmacology and therapeutics 20081201
Title: Interaction between cat's claw and protease inhibitors atazanavir, ritonavir and saquinavir.
Journal: European journal of clinical pharmacology 20081201
Title: A pilot study on the efficacy, pharmacokinetics and safety of atazanavir in patients with end-stage liver disease.
Journal: The Journal of antimicrobial chemotherapy 20081201
Title: Population pharmacokinetics of atazanavir in human immunodeficiency virus-infected patients.
Journal: Therapeutic drug monitoring 20081201
Title: An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patients.
Journal: Therapeutic drug monitoring 20081201
Title: Atazanavir: its role in HIV treatment.
Journal: Expert review of anti-infective therapy 20081201
Title: CASTLE analysis finds no benefit for once daily dosing.
Journal: Project Inform perspective 20081201
Title: 96-week data from CASTLE study presented.
Journal: Project Inform perspective 20081201
Title: Report from the 2008 joint ICAAC/IDSA meeting. Darunavir and atazanavir: 96-week data from ARTEMIS and CASTLE.
Journal: AIDS clinical care 20081201
Title: Once-daily fosamprenavir with ritonavir in the treatment of HIV infection in therapy-naïve patients.
Journal: Therapeutics and clinical risk management 20081201
Title: [Introduction. Usefulness of atazanavir in the treatment of patients infected by human immunodeficiency virus].
Journal: Enfermedades infecciosas y microbiologia clinica 20081201
Title: [Pharmacology, pharmacokinetic features and interactions of atazanavir].
Journal: Enfermedades infecciosas y microbiologia clinica 20081201
Title: [Efficacy of atazanavir in treatment-naive patients].
Journal: Enfermedades infecciosas y microbiologia clinica 20081201
Title: [Efficacy of atazanavir in simplification regimens].
Journal: Enfermedades infecciosas y microbiologia clinica 20081201
Title: [Efficacy of atazanavir in rescue therapy].
Journal: Enfermedades infecciosas y microbiologia clinica 20081201
Title: [Viral resistance and genetic barrier of atazanavir].
Journal: Enfermedades infecciosas y microbiologia clinica 20081201
Title: [Lipid profile of atazanavir].
Journal: Enfermedades infecciosas y microbiologia clinica 20081201
Title: [Adverse effects of atazanavir].
Journal: Enfermedades infecciosas y microbiologia clinica 20081201
Title: [Safety of atazanavir in patients with HIV and hepatitis B and/or C virus coinfection].
Journal: Enfermedades infecciosas y microbiologia clinica 20081201
Title: [Utility of atazanavir in special populations].
Journal: Enfermedades infecciosas y microbiologia clinica 20081201
Title: [Clinical utility of atazanavir].
Journal: Enfermedades infecciosas y microbiologia clinica 20081201
Title: Increase in serum bilirubin in HIV/hepatitis-C virus-coinfected patients on atazanavir therapy following initiation of pegylated-interferon and ribavirin.
Journal: AIDS (London, England) 20081130
Title: Emtricitabine: Inhibitor and substrate of multidrug resistance associated protein.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20081115
Title: Elevated alkaline phosphatase with raltegravir in a treatment experienced HIV patient.
Journal: AIDS (London, England) 20081112
Title: Platelet-leucocyte adhesion markers before and after the initiation of antiretroviral therapy with HIV protease inhibitors.
Journal: The Journal of antimicrobial chemotherapy 20081101
Title: Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C-->T) with reduced concentrations of unboosted atazanavir.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20081101
Title: Rapid allelic discrimination by TaqMan PCR for the detection of the Gilbert's syndrome marker UGT1A1*28.
Journal: The Journal of molecular diagnostics : JMD 20081101
Title: Nucleoside-free boosted double PI regimen: significant CD4+ T-cell recovery in patients with poor immunologic response despite virologic suppression.
Journal: Current HIV research 20081101
Title: 96-week CASTLE data show similar efficacy results.
Journal: AIDS patient care and STDs 20081101
Title: FDA notifications. Alternative dosing regimen for atazanavir is approved.
Journal: AIDS alert 20081101
Title: Clinical pharmacology of HIV protease inhibitors in pregnancy.
Journal: Current opinion in HIV and AIDS 20081101
Title: [Pharmacokinetics and interactions of raltegravir].
Journal: Enfermedades infecciosas y microbiologia clinica 20081101
Title: Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line.
Journal: Pharmaceutical research 20081001
Title: Trends in the prescription of antiretroviral drugs and impact on plasma HIV-RNA measurements.
Journal: The Journal of antimicrobial chemotherapy 20081001
Title: Acute renal failure due to bilateral ureteral stone impaction in an HIV-positive patient.
Journal: Urological research 20081001
Title: Maraviroc: in vitro assessment of drug-drug interaction potential.
Journal: British journal of clinical pharmacology 20081001
Title: Low-dose, once-daily atazanavir/ritonavir (200/100): an effective treatment for HIV-infected patients in Thailand.
Journal: Journal of acquired immune deficiency syndromes (1999) 20081001
Title: FDA notifications. Updates made to Reyataz package insert.
Journal: AIDS alert 20081001
Title: Pharmacokinetic properties and tolerability of bevirimat and atazanavir in healthy volunteers: an open-label, parallel-group study.
Journal: Clinical therapeutics 20081001
Title: Lopinavir/ritonavir in the treatment of HIV-1 infection: a review.
Journal: Therapeutics and clinical risk management 20081001
Title: Suboptimal inhibition of protease activity in human immunodeficiency virus type 1: effects on virion morphogenesis and RNA maturation.
Journal: Virology 20080915
Title: The steady-state pharmacokinetics of atazanavir/ritonavir in HIV-1-infected adult outpatients is not affected by gender-related co-factors.
Journal: The Journal of antimicrobial chemotherapy 20080901
Title: A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
Journal: Antiviral research 20080901
Title: Comparison of ABC transporter modulation by atazanavir in lymphocytes and human brain endothelial cells: ABC transporters are involved in the atazanavir-limited passage across an in vitro human model of the blood-brain barrier.
Journal: AIDS research and human retroviruses 20080901
Title: Labeling changes for Reyataz.
Journal: AIDS patient care and STDs 20080901
Title: CASTLE data show no gender differences.
Journal: AIDS patient care and STDs 20080901
Title: Correlation between HIV-1 RNA load in blood and seminal plasma depending on antiretroviral treatment status, regimen and penetration of semen by antiretroviral drugs.
Journal: Current HIV research 20080901
Title: HIV infection in the elderly.
Journal: Clinical interventions in aging 20080901
Title: A king in the CASTLE? Optimum initial HIV protease inhibitor.
Journal: Lancet (London, England) 20080823
Title: Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study.
Journal: Lancet (London, England) 20080823
Title: Electrocardiographic changes in HIV-infected, drug experienced patients treated with atazanavir.
Journal: AIDS (London, England) 20080820
Title: A study of the analytical behaviour of selected new molecular entities using electrospray ionisation ion trap mass spectrometry, liquid chromatography, gas chromatography and polarography and their determination in serum at therapeutic concentrations.
Journal: Analytica chimica acta 20080815
Title: No impairment of endothelial function or insulin sensitivity with 4 weeks of the HIV protease inhibitors atazanavir or lopinavir-ritonavir in healthy subjects without HIV infection: a placebo-controlled trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080815
Title: Inorganic polyhedral metallacarborane inhibitors of HIV protease: a new approach to overcoming antiviral resistance.
Journal: Journal of medicinal chemistry 20080814
Title: CYP3A induction and inhibition by different antiretroviral regimens reflected by changes in plasma 4beta-hydroxycholesterol levels.
Journal: European journal of clinical pharmacology 20080801
Title: The HIV-1 protease resistance mutation I50L is associated with resistance to atazanavir and susceptibility to other protease inhibitors in multiple mutational contexts.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20080801
Title: A case of HIV co-infected with hepatitis B virus precore/core deletion mutant treated by entecavir.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology 20080801
Title: Neutralizing antibody and anti-retroviral drug sensitivities of HIV-1 isolates resistant to small molecule CCR5 inhibitors.
Journal: Virology 20080801
Title: Ritonavir-boosted atazanavir, methadone, and ventricular tachycardia: 2 case reports.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080801
Title: Determination of unbound antiretroviral drug concentrations by a modified ultrafiltration method reveals high variability in the free fraction.
Journal: Therapeutic drug monitoring 20080801
Title: Time to virological failure with atazanavir/ritonavir and lopinavir/ritonavir, with or without an H2-receptor blocker, not significantly different in HIV observational database study.
Journal: International journal of STD & AIDS 20080801
Title: Two cases of multidrug-resistant human immunodeficiency virus infection treated with atazanavir and lopinavir/ritonavir combination therapy.
Journal: Journal of Korean medical science 20080801
Title: Combating HIV resistance - focus on darunavir.
Journal: Therapeutics and clinical risk management 20080801
Title: The Relationship Between HIV Infection and Cardiovascular Disease.
Journal: Current cardiology reviews 20080801
Title: Effect of atazanavir and ritonavir on the differentiation and adipokine secretion of human subcutaneous and omental preadipocytes.
Journal: AIDS (London, England) 20080711
Title: HIV protease inhibitors that block GLUT4 precipitate acute, decompensated heart failure in a mouse model of dilated cardiomyopathy.
Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20080701
Title: Cellular accumulation of cholyl-glycylamido-fluorescein in sandwich-cultured rat hepatocytes: kinetic characterization, transport mechanisms, and effect of human immunodeficiency virus protease inhibitors.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20080701
Title: Family 1 uridine-5'-diphosphate glucuronosyltransferases (UGT1A): from Gilbert's syndrome to genetic organization and variability.
Journal: Archives of toxicology 20080701
Title: Atazanavir modestly increases plasma levels of raltegravir in healthy subjects.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080701
Title: Determination of atazanavir in human plasma by high-performance liquid chromatography with UV detection.
Journal: Journal of chromatographic science 20080701
Title: Differential effects of ketoconazole on exposure to temsirolimus following intravenous infusion of temsirolimus.
Journal: British journal of cancer 20080603
Title: Quality control of protease inhibitors.
Journal: Journal of pharmaceutical sciences 20080601
Title: The genotypic inhibitory quotient: a predictive factor of atazanavir response in HIV-1-infected treatment-experienced patients.
Journal: Journal of acquired immune deficiency syndromes (1999) 20080601
Title: Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives.
Journal: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 20080601
Title: Switch from ritonavir-boosted to unboosted atazanavir guided by therapeutic drug monitoring.
Journal: AIDS research and human retroviruses 20080601
Title: Pharmacogenetics of Gilbert's syndrome.
Journal: Pharmacogenomics 20080601
Title: Long-term pharmacokinetic efficacy and safety of low-dose ritonavir as a booster and atazanavir pharmaceutical formulation based on solid dispersion system in rats.
Journal: Biological & pharmaceutical bulletin 20080601
Title: Effects of atazanavir/ritonavir or fosamprenavir/ritonavir on the pharmacokinetics of rosuvastatin.
Journal: Journal of cardiovascular pharmacology 20080601
Title: Screening and Management of HIV-2-Infected Individuals in Northern Italy.
Journal: AIDS patient care and STDs 20080601
Title: Pharmacogenomics of antiretrovirals.
Journal: Recent patents on anti-infective drug discovery 20080601
Title: Response of feline immunodeficiency virus (FIV) to tipranavir may provide new clues for development of broad-based inhibitors of retroviral proteases acting on drug-resistant HIV-1.
Journal: Current HIV research 20080601
Title: Atriplatrade mark - HIV therapy in one pill.
Journal: Therapeutics and clinical risk management 20080601
Title: Stability of antiretroviral regimens in patients with viral suppression.
Journal: AIDS (London, England) 20080531
Title: Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography-triple quadrupole mass spectrometry.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080515
Title: Effects of acid-reducing agents on the pharmacokinetics of lopinavir/ritonavir and ritonavir-boosted atazanavir.
Journal: Journal of clinical pharmacology 20080501
Title: The compound 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid inhibits HIV-1 replication by targeting the enzyme reverse transcriptase.
Journal: Current HIV research 20080501
Title: [Acute renal failure associated with the use of tenofovir combined with atazanavir in patients with HIV infection].
Journal: Enfermedades infecciosas y microbiologia clinica 20080501
Title: FDA notifications. Atazanavir capsule label is updated for pediatric patients.
Journal: AIDS alert 20080501
Title: [Toxicogenetics of antiretroviral treatment (II): neurotoxicity, hepatotoxicity, lactic acidosis, kidney damage, and other adverse effects of antiretroviral drugs].
Journal: Enfermedades infecciosas y microbiologia clinica 20080501
Title: [Applicability of pharmacogenetic studies in daily clinical practice].
Journal: Enfermedades infecciosas y microbiologia clinica 20080501
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20080501
Title: Inhibitory quotient in HIV pharmacology.
Journal: Current opinion in HIV and AIDS 20080501
Title: Differences in the pharmacokinetics of protease inhibitors between healthy volunteers and HIV-infected persons.
Journal: Current opinion in HIV and AIDS 20080501
Title: [Metabolic changes in PI-based HAART. Change to atazanavir: continued effectiveness with improved lipid profile].
Journal: MMW Fortschritte der Medizin 20080428
Title: Diagnosis and management of HIV drug hypersensitivity.
Journal: The Journal of allergy and clinical immunology 20080401
Title: Characterization of a novel human immunodeficiency virus type 1 protease inhibitor, A-790742.
Journal: Antimicrobial agents and chemotherapy 20080401
Title: Liver toxicity of antiretroviral combinations including atazanavir/ritonavir in patients co-infected with HIV and hepatitis viruses: impact of pre-existing liver fibrosis.
Journal: The Journal of antimicrobial chemotherapy 20080401
Title: Inhibition of HIV-2 protease by HIV-1 protease inhibitors in clinical use.
Journal: Chemical biology & drug design 20080401
Title: Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers.
Journal: British journal of clinical pharmacology 20080401
Title: Atazanavir and lopinavir with ritonavir alone or in combination: analysis of pharmacokinetic interaction and predictors of drug exposure.
Journal: HIV medicine 20080401
Title: New pediatric dosing recommendations for atazanavir.
Journal: AIDS patient care and STDs 20080401
Title: Risk of early virological failure of once-daily tenofovir-emtricitabine plus twice-daily nevirapine in antiretroviral therapy-naive HIV-infected patients.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080401
Title: Raltegravir: first in class HIV integrase inhibitor.
Journal: Therapeutics and clinical risk management 20080401
Title: Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen.
Journal: HIV medicine 20080301
Title: Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006.
Journal: HIV medicine 20080301
Title: Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus.
Journal: Pharmacotherapy 20080301
Title: CASTLE study showed similar efficacy.
Journal: AIDS patient care and STDs 20080301
Title: Revised package insert for atazanavir.
Journal: AIDS clinical care 20080301
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20080301
Title: FDA notifications. FDA tentatively approves generic atazanavir.
Journal: AIDS alert 20080301
Title: FDA notifications. Revised atazanavir package insert.
Journal: AIDS alert 20080301
Title: Anti-HIV agents. The Castle study: lopinavir vs. atazanavir.
Journal: TreatmentUpdate 20080301
Title: Two-carbon-elongated HIV-1 protease inhibitors with a tertiary-alcohol-containing transition-state mimic.
Journal: Journal of medicinal chemistry 20080227
Title: Efficacy and safety of atazanavir, with or without ritonavir, as part of once-daily highly active antiretroviral therapy regimens in antiretroviral-naive patients.
Journal: Journal of acquired immune deficiency syndromes (1999) 20080201
Title: Structure-activity relationships of novel HIV-1 protease inhibitors containing the 3-amino-2-chlorobenzoyl-allophenylnorstatine structure.
Journal: Bioorganic & medicinal chemistry 20080201
Title: Evolution of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20080201
Title: Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infection.
Journal: Antimicrobial agents and chemotherapy 20080201
Title: A ten-year analysis of the incidence and risk factors for acute pancreatitis requiring hospitalization in an urban HIV clinical cohort.
Journal: AIDS patient care and STDs 20080201
Title: Improvement in insulin sensitivity and dyslipidemia in protease inhibitor-treated adult male patients after switch to atazanavir/ritonavir.
Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research 20080201
Title: Progression of Kaposi sarcoma associated with iatrogenic Cushing syndrome in a person with HIV/AIDS.
Journal: The AIDS reader 20080201
Title: Urolithiasis under atazanavir boosted and tenofovir therapy: a case report.
Journal: Journal of chemotherapy (Florence, Italy) 20080201
Title: Atazanavir/ritonavir: a review of its use in HIV therapy.
Journal: Drugs of today (Barcelona, Spain : 1998) 20080201
Title: Long-distance interactive expert advice in highly treatment-experienced HIV-infected patients.
Journal: The Journal of antimicrobial chemotherapy 20080101
Title: Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial.
Journal: The Journal of antimicrobial chemotherapy 20080101
Title: HIV-1 protease inhibitors: effects on HIV-2 replication and resistance.
Journal: Trends in pharmacological sciences 20080101
Title: Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the CARe Study.
Journal: AIDS patient care and STDs 20080101
Title: Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir.
Journal: Journal of acquired immune deficiency syndromes (1999) 20080101
Title: Drug interactions between HIV protease inhibitors and acid-reducing agents.
Journal: Clinical pharmacokinetics 20080101
Title: Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice.
Journal: PLoS medicine 20080101
Title: The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001-2006) in Portugal.
Journal: Retrovirology 20080101
Title: Implementation and effectiveness of antiretroviral therapy in Greenland.
Journal: Emerging infectious diseases 20080101
Title: Adaptation of antiretroviral therapy in human immunodeficiency virus infection with central nervous system involvement.
Journal: Journal of neurovirology 20080101
Title: Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.
Journal: BMC infectious diseases 20080101
Title: Efficacy and safety of once-daily regimens in the treatment of HIV infection.
Journal: Drugs 20080101
Title: Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT.
Journal: AIDS research and therapy 20080101
Title: Acute renal failure in an AIDS patient on tenofovir: a case report.
Journal: Journal of medical case reports 20080101
Title: Proteochemometric modeling of HIV protease susceptibility.
Journal: BMC bioinformatics 20080101
Title: Case presentation: nephrolithiasis in a patient treated with atazanavir.
Journal: The Journal of the Association of Nurses in AIDS Care : JANAC 20080101
Title: Atazanavir in patients with persistent viral replication despite HAART: results from the French prospective NADIS cohort.
Journal: HIV clinical trials 20080101
Title: Once-daily abacavir/lamivudine and ritonavir-boosted atazanavir for the treatment of HIV-1 infection in antiretroviral-naïve patients: a 48-week pilot study.
Journal: HIV clinical trials 20080101
Title: An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load.
Journal: PloS one 20080101
Title: The inverse starving test is not a suitable provocation test for Gilbert's syndrome.
Journal: BMC research notes 20080101
Title: Evaluation of efficacy, safety, pharmacokinetics, and adherence in HIV-1-infected, antiretroviral-naïve patients treated with ritonavir-boosted atazanavir plus fixed-dose tenofovir DF/emtricitabine given once daily.
Journal: HIV clinical trials 20080101
Title: Significant improvements in self-reported gastrointestinal tolerability, quality of life, patient satisfaction, and adherence with lopinavir/ritonavir tablet formulation compared with soft gel capsules.
Journal: AIDS research and therapy 20080101
Title: Resting regulatory CD4 T cells: a site of HIV persistence in patients on long-term effective antiretroviral therapy.
Journal: PloS one 20080101
Title: Gateways to clinical trials. July-August 2008.
Journal: Methods and findings in experimental and clinical pharmacology 20080101
Title: Dyslipidemia and cardiovascular disease risk factor management in HIV-1-infected subjects treated with HAART in the Spanish VACH cohort.
Journal: The open AIDS journal 20080101
Title: Double-boosted protease inhibitor antiretroviral regimens: what role?
Journal: Drugs 20080101
Title: Magnitude and complexity of rectal mucosa HIV-1-specific CD8+ T-cell responses during chronic infection reflect clinical status.
Journal: PloS one 20080101
Title: Prevention of the sexual transmission of HIV-1: preparing for success.
Journal: Journal of the International AIDS Society 20080101
Title: Pharmacokinetics of atazanavir/ritonavir once daily and lopinavir/ritonavir twice and once daily over 72 h following drug cessation.
Journal: Antiviral therapy 20080101
Title: XVII International AIDS Conference--Mexico City, August 3-8, 2008. Metabolic complications and hepatitis co-infection. News from the International AIDS Conference.
Journal: Positively aware : the monthly journal of the Test Positive Aware Network 20080101
Title: Role of genetic diversity amongst HIV-1 non-B subtypes in drug resistance: a systematic review of virologic and biochemical evidence.
Journal: AIDS reviews 20080101
Title: [Simplification of HAART scheme--treatment optimization].
Journal: Terapevticheskii arkhiv 20080101
Title: Efficacy and safety of ritonavir-boosted and unboosted atazanavir among antiretroviral-naïve patients.
Journal: HIV clinical trials 20080101
Title: Determinants of Treatment Access in a Population-based Cohort of HIV-positive Men and Women Living in Argentina.
Journal: Journal of the International AIDS Society 20080101
Title: Raltegravir in the management of HIV-infected patients.
Journal: Drug design, development and therapy 20080101
Title: Interaction between buprenorphine and atazanavir or atazanavir/ritonavir.
Journal: Drug and alcohol dependence 20071201
Title: Overview of boosted protease inhibitors in treatment-experienced HIV-infected patients.
Journal: The Journal of antimicrobial chemotherapy 20071201
Title: Initiating highly active antiretroviral therapy with newer protease inhibitors is associated with better survival compared to first-generation protease inhibitors or nevirapine.
Journal: AIDS patient care and STDs 20071201
Title: Characterization of HIV-1 subtypes and viral antiretroviral drug resistance in men who have sex with men in Beijing, China.
Journal: AIDS (London, England) 20071201
Title: Review of tenofovir-emtricitabine.
Journal: Therapeutics and clinical risk management 20071201
Title: Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer.
Journal: AIDS (London, England) 20071130
Title: HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20071115
Title: HIV-1 protease inhibitors nelfinavir and atazanavir induce malignant glioma death by triggering endoplasmic reticulum stress.
Journal: Cancer research 20071115
Title: Atazanavir crystal nephropathy.
Journal: AIDS (London, England) 20071112
Title: Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity.
Journal: AIDS (London, England) 20071112
Title: HIV protease inhibitors increase TNF-alpha and IL-6 expression in macrophages: involvement of the RNA-binding protein HuR.
Journal: Atherosclerosis 20071101
Title: Inhibition of P-glycoprotein and multidrug resistance-associated proteins modulates the intracellular concentration of lopinavir in cultured CD4 T cells and primary human lymphocytes.
Journal: The Journal of antimicrobial chemotherapy 20071101
Title: Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.
Journal: PLoS medicine 20071101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20071101
Title: Urolithiasis in HIV-positive patients treated with atazanavir.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20071015
Title: Prevalence of darunavir resistance mutations in HIV-1-infected patients failing other protease inhibitors.
Journal: The Journal of antimicrobial chemotherapy 20071001
Title: Tenofovir comedication does not impair the steady-state pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected adults.
Journal: European journal of clinical pharmacology 20071001
Title: Therapeutic drug monitoring of the HIV protease inhibitor atazanavir in clinical practice.
Journal: The Journal of antimicrobial chemotherapy 20071001
Title: Gene expression profiling of rat liver reveals a mechanistic basis for ritonavir-induced hyperlipidemia.
Journal: Genomics 20071001
Title: Steady-state pharmacokinetics of once-daily fosamprenavir/ritonavir and atazanavir/ritonavir alone and in combination with 20 mg omeprazole in healthy volunteers.
Journal: HIV medicine 20071001
Title: Treatment of an atazanivir associated grade 4 hyperbilirubinaemia with efavirenz.
Journal: Gut 20071001
Title: Assessing the impact of substance use and hepatitis coinfection on atazanavir and lopinavir trough concentrations in HIV-infected patients during therapeutic drug monitoring.
Journal: Therapeutic drug monitoring 20071001
Title: Monitoring atazanavir concentrations with boosted or unboosted regimens in HIV-infected patients in routine clinical practice.
Journal: Therapeutic drug monitoring 20071001
Title: Reyataz monotherapy study stopped.
Journal: Project Inform perspective 20071001
Title: Potent inhibition of HIV-1 replication by novel non-peptidyl small molecule inhibitors of protease dimerization.
Journal: The Journal of biological chemistry 20070928
Title: Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis.
Journal: AIDS (London, England) 20070912
Title: Efavirenz urolithiasis.
Journal: AIDS (London, England) 20070912
Title: Design and synthesis of HIV-1 protease inhibitors incorporating oxazolidinones as P2/P2' ligands in pseudosymmetric dipeptide isosteres.
Journal: Journal of medicinal chemistry 20070906
Title: Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily.
Journal: Antimicrobial agents and chemotherapy 20070901
Title: In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV.
Journal: Antimicrobial agents and chemotherapy 20070901
Title: Interactions between protease inhibitors and acid-reducing agents: a systematic review.
Journal: HIV medicine 20070901
Title: Modulation of heme and myristate binding to human serum albumin by anti-HIV drugs. An optical and NMR spectroscopic study.
Journal: The FEBS journal 20070901
Title: Atazanavir-associated menorrhagia.
Journal: International journal of STD & AIDS 20070901
Title: Patient preferences among third agent HIV medications: a US and German perspective.
Journal: AIDS care 20070901
Title: Early virologic rebound in a pilot trial of ritonavir-boosted atanazavir as maintenance monotherapy.
Journal: Journal of acquired immune deficiency syndromes (1999) 20070901
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20070901
Title: Virological failure and subsequent resistance profiles in individuals exposed to atazanavir.
Journal: AIDS (London, England) 20070820
Title: Review of tipranavir in the treatment of drug-resistant HIV.
Journal: Therapeutics and clinical risk management 20070801
Title: Electrocardiographic changes in HIV-infected, drug-experienced patients being treated with atazanavir.
Journal: AIDS (London, England) 20070731
Title: [Insulin resistance in HIV-infected patients receiving long-term therapy with efavirenz, lopinavir/ritonavir and atazanavir].
Journal: Medicina clinica 20070714
Title: Methadone dosing strategies in HIV-infected injection drug users enrolled in a directly observed therapy program.
Journal: Journal of acquired immune deficiency syndromes (1999) 20070701
Title: Interindividual variability in the effect of atazanavir and saquinavir on the expression of lymphocyte P-glycoprotein.
Journal: The Journal of antimicrobial chemotherapy 20070701
Title: Optimal timing and duration of induction therapy for HIV-1 infection.
Journal: PLoS computational biology 20070701
Title: Antiretroviral therapy-induced liver alterations.
Journal: Current opinion in HIV and AIDS 20070701
Title: The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial.
Journal: AIDS (London, England) 20070619
Title: Alopecia associated with ritonavir-boosted atazanavir therapy.
Journal: AIDS (London, England) 20070619
Title: Variability in non-nucleoside reverse transcriptase and protease inhibitors concentrations among HIV-infected adults in routine clinical practice.
Journal: British journal of clinical pharmacology 20070601
Title: A novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI), GRL-98065, is potent against multiple-PI-resistant human immunodeficiency virus in vitro.
Journal: Antimicrobial agents and chemotherapy 20070601
Title: Beneficial pharmacokinetic interaction between atazanavir and lopinavir/ritonavir.
Journal: Journal of acquired immune deficiency syndromes (1999) 20070601
Title: Acute interstitial nephritis of HIV-positive patients under atazanavir and tenofovir therapy in a retrospective analysis of kidney biopsies.
Journal: Virchows Archiv : an international journal of pathology 20070601
Title: The safety, efficacy, and pharmacokinetic profile of a switch in antiretroviral therapy to saquinavir, ritonavir, and atazanavir alone for 48 weeks and a switch in the saquinavir formulation.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070601
Title: Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: the SWAN Study (AI424-097) 48-week results.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070601
Title: Cushing syndrome and severe adrenal suppression caused by fluticasone and protease inhibitor combination in an HIV-infected adolescent.
Journal: AIDS patient care and STDs 20070601
Title: Atazanavir-associated nephrolithiasis: cases from the US Food and Drug Administration's Adverse Event Reporting System.
Journal: AIDS (London, England) 20070531
Title: Atazanavir-containing renal calculi in an HIV-infected patient.
Journal: AIDS (London, England) 20070511
Title: Buprenorphine assay and plasma concentration monitoring in HIV-infected substance users.
Journal: Journal of pharmaceutical and biomedical analysis 20070509
Title: Determination of 19 antiretroviral agents in pharmaceuticals or suspected products with two methods using high-performance liquid chromatography.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070501
Title: Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients.
Journal: Current drug safety 20070501
Title: Combining resistance and pharmacology for optimum patient care.
Journal: Current opinion in HIV and AIDS 20070501
Title: Atazanavir in plasma-exchange treatment.
Journal: AIDS (London, England) 20070423
Title: Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial.
Journal: Lancet (London, England) 20070414
Title: An isocratic liquid chromatography method for determining HIV non-nucleoside reverse transcriptase inhibitor and protease inhibitor concentrations in human plasma.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070401
Title: Early virologic rebound in a pilot trial of ritonavir-boosted atazanavir as maintenance monotherapy.
Journal: Journal of acquired immune deficiency syndromes (1999) 20070401
Title: Influence of liver fibrosis stage on plasma levels of antiretroviral drugs in HIV-infected patients with chronic hepatitis C.
Journal: The Journal of infectious diseases 20070401
Title: Atazanavir: simplicity and convenience in different scenarios.
Journal: Expert opinion on pharmacotherapy 20070401
Title: Switching to unboosted atazanavir improves glucose tolerance in highly pretreated HIV-1 infected subjects.
Journal: European journal of endocrinology 20070401
Title: Pharmaceutical approach to HIV protease inhibitor atazanavir for bioavailability enhancement based on solid dispersion system.
Journal: Biological & pharmaceutical bulletin 20070401
Title: Antiviral activity and clinical efficacy of atazanavir in HIV-1-infected patients: a review.
Journal: The new microbiologica 20070401
Title: Impact of modelling intra-subject variability on tests based on non-linear mixed-effects models in cross-over pharmacokinetic trials with application to the interaction of tenofovir on atazanavir in HIV patients.
Journal: Statistics in medicine 20070315
Title: Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070315
Title: High-performance liquid chromatography assay for the determination of the HIV-protease inhibitor tipranavir in human plasma in combination with nine other antiretroviral medications.
Journal: Journal of pharmaceutical and biomedical analysis 20070312
Title: Modification of tandem mass spectrometric method to permit simultaneous quantification of 17 anti-HIV drugs which include atazanavir and tipranavir.
Journal: Clinica chimica acta; international journal of clinical chemistry 20070301
Title: Multidrug resistance 1 polymorphisms and trough concentrations of atazanavir and lopinavir in patients with HIV.
Journal: Pharmacogenomics 20070301
Title: Quality of life in HIV clinical trials: why sexual health must not be ignored.
Journal: PLoS clinical trials 20070301
Title: Pharmacokinetic interaction between rifampicin and ritonavir-boosted atazanavir in HIV-infected patients.
Journal: HIV medicine 20070301
Title: Development and validation of a preclinical food effect model.
Journal: Journal of pharmaceutical sciences 20070201
Title: Modulation of human BCRP (ABCG2) activity by anti-HIV drugs.
Journal: The Journal of antimicrobial chemotherapy 20070201
Title: Pharmacokinetics of saquinavir with atazanavir or low-dose ritonavir administered once daily (ASPIRE I) or twice daily (ASPIRE II) in seronegative volunteers.
Journal: Journal of clinical pharmacology 20070201
Title: Monopolizing clinical trial data: implications and trends.
Journal: PLoS medicine 20070201
Title: Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application.
Journal: Therapeutic drug monitoring 20070201
Title: Update in HIV care.
Journal: Journal of general internal medicine 20070201
Title: Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia.
Journal: AIDS (London, England) 20070102
Title: Simultaneous determination of 8 HIV protease inhibitors in human plasma by isocratic high-performance liquid chromatography with combined use of UV and fluorescence detection: amprenavir, indinavir, atazanavir, ritonavir, lopinavir, saquinavir, nelfinavir and M8-nelfinavir metabolite.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070101
Title: Cost effectiveness of lopinavir/ritonavir compared with atazanavir in antiretroviral-naive patients: modelling the combined effects of HIV and heart disease.
Journal: Clinical drug investigation 20070101
Title: A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism.
Journal: PLoS medicine 20070101
Title: A comparison of different protease inhibitors on coronary heart disease risk.
Journal: Connecticut medicine 20070101
Title: HIV-1 integrase inhibitors are substrates for the multidrug transporter MDR1-P-glycoprotein.
Journal: Retrovirology 20070101
Title: Renal function in antiretroviral-experienced patients treated with tenofovir disoproxil fumarate associated with atazanavir/ritonavir.
Journal: Antiviral therapy 20070101
Title: AIDS in the Third World: how to stop the HIV infection?
Journal: Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie 20070101
Title: Anti-HIV drugs.
Journal: Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie 20070101
Title: Cost effectiveness of lopinavir/ritonavir compared with atazanavir plus ritonavir in antiretroviral-experienced patients in the US.
Journal: Clinical drug investigation 20070101
Title: Synergistic inhibition of protease-inhibitor-resistant HIV type 1 by saquinavir in combination with atazanavir or lopinavir.
Journal: Antiviral therapy 20070101
Title: Pharmacokinetics of darunavir (TMC114) and atazanavir during coadministration in HIV-negative, healthy volunteers.
Journal: Drugs in R&D 20070101
Title: Fast and simultaneous determination of darunavir and eleven other antiretroviral drugs for therapeutic drug monitoring: method development and validation for the determination of all currently approved HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
Journal: Rapid communications in mass spectrometry : RCM 20070101
Title: Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin, amiodarone, and atazanavir.
Journal: Journal of the American Board of Family Medicine : JABFM 20070101
Title: Electrospray tandem mass spectroscopic characterisation of 18 antiretroviral drugs and simultaneous quantification of 12 antiretrovirals in plasma.
Journal: Rapid communications in mass spectrometry : RCM 20070101
Title: A randomized trial evaluating Prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain.
Journal: PloS one 20070101
Title: Validation of the SCID-hu Thy/Liv mouse model with four classes of licensed antiretrovirals.
Journal: PloS one 20070101
Title: Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages.
Journal: Antiviral therapy 20070101
Title: Abacavir plasma pharmacokinetics in the absence and presence of atazanavir/ritonavir or lopinavir/ritonavir and vice versa in HIV-infected patients.
Journal: Antiviral therapy 20070101
Title: An expanded set of amino acid analogs for the ribosomal translation of unnatural peptides.
Journal: PloS one 20070101
Title: Utilization and spending trends for antiretroviral medications in the U.S. Medicaid program from 1991 to 2005.
Journal: AIDS research and therapy 20070101
Title: Cost effectiveness of lopinavir/ritonavir tablets compared with atazanavir plus ritonavir in antiretroviral-experienced patients in the UK, France, Italy and Spain.
Journal: Clinical drug investigation 20070101
Title: Inhibitors of HIV-1 protease: current state of the art 10 years after their introduction. From antiretroviral drugs to antifungal, antibacterial and antitumor agents based on aspartic protease inhibitors.
Journal: Current medicinal chemistry 20070101
Title: Factors associated with altered pharmacokinetics in substance users and non-substance users receiving lopinavir and atazanavir.
Journal: The American journal on addictions 20070101
Title: Maraviroc: the evidence for its potential in the management of HIV.
Journal: Core evidence 20070101
Title: Renal function in patients receiving tenofovir with ritonavir/lopinavir or ritonavir/atazanavir in the HIV Outpatient Study (HOPS) cohort.
Journal: Journal of acquired immune deficiency syndromes (1999) 20061215
Title: HIV protease inhibitors activate the unfolded protein response and disrupt lipid metabolism in primary hepatocytes.
Journal: American journal of physiology. Gastrointestinal and liver physiology 20061201
Title: Meeting report. Report from ICAAC.
Journal: AIDS clinical care 20061201
Title: Atazanavir urolithiasis.
Journal: The New England journal of medicine 20061116
Title: Influence of atazanavir 200 mg on the intracellular and plasma pharmacokinetics of saquinavir and ritonavir 1600/100 mg administered once daily in HIV-infected patients.
Journal: The Journal of antimicrobial chemotherapy 20061101
Title: Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype.
Journal: Hepatology (Baltimore, Md.) 20061101
Title: Variability in non-nucleoside reverse transcriptase and protease inhibitor concentrations among HIV-infected adults in routine clinical practice.
Journal: British journal of clinical pharmacology 20061101
Title: Metabolic abnormalities in HIV-infected patients: an update.
Journal: Current infectious disease reports 20061101
Title: Acid suppressive therapy and the effects on protease inhibitors.
Journal: The Annals of pharmacotherapy 20061101
Title: Does HIV cause cardiovascular disease?
Journal: PLoS medicine 20061101
Title: Successful treatment with atazanavir and lopinavir/ritonavir combination therapy in protease inhibitor-susceptible and protease inhibitor-resistant HIV-infected patients.
Journal: AIDS patient care and STDs 20061101
Title: New atazanavir capsule approved.
Journal: AIDS patient care and STDs 20061101
Title: Suppression of HIV-1 protease inhibitor resistance by phosphonate-mediated solvent anchoring.
Journal: Journal of molecular biology 20061027
Title: Therapeutic ritonavir-boosted atazanavir plasma concentration and concurrent omeprazole use.
Journal: AIDS (London, England) 20061024
Title: Atazanavir urinary stones in an HIV-infected patient.
Journal: AIDS (London, England) 20061024
Title: Simple determination of the HIV protease inhibitor atazanavir in human plasma by high-performance liquid chromatography with UV detection.
Journal: Journal of pharmaceutical and biomedical analysis 20061011
Title: Response to 'Atazanavir/ritonavir versus lopinavir/ritonavir: equivalent or different efficacy profiles?' by Hill.
Journal: AIDS (London, England) 20061003
Title: Clinical outcomes associated with concomitant use of atazanavir and proton pump inhibitors.
Journal: The Annals of pharmacotherapy 20061001
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20061001
Title: Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity: demonstrable differences in vitro and clinically.
Journal: AIDS (London, England) 20060911
Title: Change to a once-daily combination including boosted atazanavir in HIV-1-infected children.
Journal: The Pediatric infectious disease journal 20060901
Title: Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: Part II.
Journal: Journal of psychiatric practice 20060901
Title: An update on HIV-1 antiretroviral resistance.
Journal: Current opinion in HIV and AIDS 20060901
Title: Management of antiretroviral drug toxicity.
Journal: Current opinion in HIV and AIDS 20060901
Title: Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy after sustained virologic suppression.
Journal: JAMA 20060816
Title: Further information on the administration of h2-receptor antagonists with atazanavir.
Journal: Journal of acquired immune deficiency syndromes (1999) 20060801
Title: Liquid chromatographic assay for the non-peptidic protease inhibitor tipranavir in plasma.
Journal: Biomedical chromatography : BMC 20060801
Title: An update and review of antiretroviral therapy.
Journal: Pharmacotherapy 20060801
Title: Full validation of an analytical method for the HIV-protease inhibitor atazanavir in combination with 8 other antiretroviral agents and its applicability to therapeutic drug monitoring.
Journal: Therapeutic drug monitoring 20060801
Title: Pharmacokinetics of saquinavir hard-gel/ritonavir and atazanavir when combined once daily in HIV Type 1-infected individuals administered different atazanavir doses.
Journal: AIDS research and human retroviruses 20060801
Title: Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients.
Journal: European journal of clinical pharmacology 20060701
Title: A prospective evaluation of the effect of atazanavir on the QTc interval and QTc dispersion in HIV-positive patients.
Journal: HIV medicine 20060701
Title: [Acute tubulointerstitial nephritis in HIV infection].
Journal: Praxis 20060607
Title: Can boosted atazanavir induce hyperlipotrophy?
Journal: The Journal of infection 20060601
Title: Rescue therapy with once-daily atazanavir-based regimens for antiretroviral-experienced HIV-infected patients.
Journal: Journal of acquired immune deficiency syndromes (1999) 20060601
Title: Antiretroviral drug resistance and routine therapy, Cameroon.
Journal: Emerging infectious diseases 20060601
Title: Quality assurance program for pharmacokinetic assay of antiretrovirals: ACTG proficiency testing for pediatric and adult pharmacology support laboratories, 2003 to 2004: a requirement for therapeutic drug monitoring.
Journal: Therapeutic drug monitoring 20060601
Title: HIV protease inhibitor-specific alterations in human adipocyte differentiation and metabolism.
Journal: Obesity (Silver Spring, Md.) 20060601
Title: Atazanavir and lopinavir/ritonavir: pharmacokinetics, safety and efficacy of a promising double-boosted protease inhibitor regimen.
Journal: AIDS (London, England) 20060512
Title: Skin rash associated with atazanavir: report of three cases.
Journal: AIDS (London, England) 20060512
Title: Unexpected improvement of sexual dysfunction during atazanavir therapy.
Journal: AIDS (London, England) 20060512
Title: Analysis of HIV-1 CRF_01 A/E protease inhibitor resistance: structural determinants for maintaining sensitivity and developing resistance to atazanavir.
Journal: Biochemistry 20060502
Title: Low incidence of severe liver toxicity in patients receiving antiretroviral combinations including atazanavir.
Journal: The Journal of antimicrobial chemotherapy 20060501
Title: Ritonavir-boosted atazanavir may be efficacious in HIV-infected patients concurrently receiving omeprazole.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060501
Title: External validation of atazanavir/ritonavir genotypic score in HIV-1 protease inhibitor-experienced patients.
Journal: Journal of acquired immune deficiency syndromes (1999) 20060501
Title: A single centre cohort experience with a new once daily antiretroviral drug.
Journal: Postgraduate medical journal 20060501
Title: Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy.
Journal: AIDS (London, England) 20060424
Title: Critical drug interaction between ritonavir-boosted atazanavir regimen and non-nucleoside reverse transcriptase inhibitors.
Journal: AIDS (London, England) 20060424
Title: Effect of baseline protease genotype and phenotype on HIV response to atazanavir/ritonavir in treatment-experienced patients.
Journal: AIDS (London, England) 20060404
Title: Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: the discovery of GW0385.
Journal: Bioorganic & medicinal chemistry letters 20060401
Title: Susceptibility to protease inhibitors in HIV-2 primary isolates from patients failing antiretroviral therapy.
Journal: The Journal of antimicrobial chemotherapy 20060401
Title: Effects of esomeprazole on the pharmacokinetics of atazanavir and fosamprenavir in a patient with human immunodeficiency virus infection.
Journal: Pharmacotherapy 20060401
Title: The effects of the Roche AMPLICOR HIV-1 MONITOR UltraSensitive Test versions 1.0 and 1.5 viral load assays and plasma collection tube type on determination of response to antiretroviral therapy and the inappropriateness of cross-study comparisons.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20060401
Title: Susceptibility to antiretroviral drugs of CRF01_AE, CRF02_AG, and subtype C viruses from untreated patients of Africa and Asia: comparative genotypic and phenotypic data.
Journal: AIDS research and human retroviruses 20060401
Title: Report from the 13th retrovirus conference. Extending the role of atazanavir.
Journal: AIDS clinical care 20060401
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20060401
Title: New antiretroviral drugs in clinical use.
Journal: Indian journal of pediatrics 20060401
Title: 96-week comparison of once-daily atazanavir/ritonavir and twice-daily lopinavir/ritonavir in patients with multiple virologic failures.
Journal: AIDS (London, England) 20060321
Title: Three case reports of a clinical pharmacokinetic interaction with buprenorphine and atazanavir plus ritonavir.
Journal: AIDS (London, England) 20060321
Title: Inhibition of atazanavir oral absorption by lansoprazole gastric acid suppression in healthy volunteers.
Journal: Pharmacotherapy 20060301
Title: Lack of interaction between atazanavir and proton pump inhibitors in HIV-infected patients treated with ritonavir-boosted atazanavir.
Journal: Journal of acquired immune deficiency syndromes (1999) 20060301
Title: Proton pump inhibitor therapy in atazanavir-treated patients: contraindicated?
Journal: Journal of acquired immune deficiency syndromes (1999) 20060301
Title: Inhibition of HIV-1 replication in human primary cells by a dolabellane diterpene isolated from the marine algae Dictyota pfaffii.
Journal: Planta medica 20060301
Title: Early clinical experience with atazanavir in treatment-experienced patients.
Journal: Sexual health 20060301
Title: A monolithic-phase based on-line extraction approach for determination of pharmaceutical components in human plasma by HPLC-MS/MS and a comparison with liquid-liquid extraction.
Journal: Journal of pharmaceutical and biomedical analysis 20060224
Title: Determination of the novel non-peptidic HIV-protease inhibitor tipranavir by HPLC-UV after solid-phase extraction.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060217
Title: Simultaneous determination of 16 anti-HIV drugs in human plasma by high-performance liquid chromatography.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060202
Title: Some PIs have greater impact than others on heart disease. Patients on atazanavir had less heart problems.
Journal: AIDS alert 20060201
Title: Body fat and other metabolic effects of atazanavir and efavirenz, each administered in combination with zidovudine plus lamivudine, in antiretroviral-naive HIV-infected patients.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060115
Title: Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060115
Title: Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C-->T polymorphism at the multidrug resistance gene 1.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060115
Title: Human placental transfer of atazanavir: a case report.
Journal: AIDS (London, England) 20060109
Title: Clinical validation of atazanavir/ritonavir genotypic resistance score in protease inhibitor-experienced patients.
Journal: AIDS (London, England) 20060102
Title: A case of transient hyperphosphatasemia of infancy and early childhood in an HIV-positive adult possibly related to atazanavir.
Journal: AIDS (London, England) 20060102
Title: Liquid chromatographic assay for the protease inhibitor atazanavir in plasma.
Journal: Biomedical chromatography : BMC 20060101
Title: Interaction between atazanavir and fosamprenavir in the treatment of HIV-infected patients.
Journal: Journal of acquired immune deficiency syndromes (1999) 20060101
Title: Update on HAART in HIV.
Journal: Journal of hepatology 20060101
Title: Antiviral hepatitis and antiretroviral drug interactions.
Journal: Journal of hepatology 20060101
Title: Understanding and avoiding antiretroviral adverse events.
Journal: Current pharmaceutical design 20060101
Title: Ritonavir-boosted atazanavir-lopinavir combination: a pharmacokinetic interaction study of total, unbound plasma and cellular exposures.
Journal: Antiviral therapy 20060101
Title: Direct and fast determination of antiretroviral drugs by automated online solid-phase extraction-liquid chromatography-tandem mass spectrometry in human plasma.
Journal: Clinical chemistry and laboratory medicine 20060101
Title: DR_SEQAN: a PC/Windows-based software to evaluate drug resistance using human immunodeficiency virus type 1 genotypes.
Journal: BMC infectious diseases 20060101
Title: Antiretroviral treatment of HIV infection: Swedish recommendations 2005.
Journal: Scandinavian journal of infectious diseases 20060101
Title: Atazanavir plasma concentrations vary significantly between patients and correlate with increased serum bilirubin concentrations.
Journal: HIV clinical trials 20060101
Title: Salvage therapy with atazanavir/ritonavir combined to tenofovir in HIV-infected patients with multiple treatment failures: randomized ANRS 107 trial.
Journal: Antiviral therapy 20060101
Title: Lopinavir/ritonavir: a review of its use in the management of HIV infection.
Journal: Drugs 20060101
Title: Virological responses to atazanavir-ritonavir-based regimens: resistance-substitutions score and pharmacokinetic parameters (Reyaphar study).
Journal: Antiviral therapy 20060101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20060101
Title: Performance of six different ritonavir-boosted protease inhibitor-based regimens in heavily antiretroviral-experienced HIV-infected patients.
Journal: HIV clinical trials 20060101
Title: Cardiovascular risk in patients with HIV Infection: impact of antiretroviral therapy.
Journal: Drugs 20060101
Title: Cost to achieve an undetectable viral load using recommended antiretroviral regimens.
Journal: HIV clinical trials 20060101
Title: Fosamprenavir clinical study meta-analysis in ART-naïve subjects: rare occurrence of virologic failure and selection of protease-associated mutations.
Journal: HIV clinical trials 20060101
Title: Drug interactions. Is atazanavir best when boosted with ritonavir?
Journal: TreatmentUpdate 20060101
Title: Drug interactions. Atazanavir and acid-reducing agents.
Journal: TreatmentUpdate 20060101
Title: Drug interactions. Brecanavir--a new protease inhibitor.
Journal: TreatmentUpdate 20060101
Title: Drug interactions. Kaletra and atazanavir.
Journal: TreatmentUpdate 20060101
Title: Switching strategies to improve lipid profile and morphologic changes.
Journal: AIDS reviews 20060101
Title: Specific HIV protease inhibitors inhibit the ability of HPV16 E6 to degrade p53 and selectively kill E6-dependent cervical carcinoma cells in vitro.
Journal: Antiviral therapy 20060101
Title: Disease Management - Constructing Optimal NRTI-Based Combinations: Past, Present, and Future.
Journal: Journal of the International AIDS Society 20060101
Title: Simultaneous determination of HIV protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20051227
Title: Direct comparison of the acute in vivo effects of HIV protease inhibitors on peripheral glucose disposal.
Journal: Journal of acquired immune deficiency syndromes (1999) 20051201
Title: Allosteric modulation of anti-HIV drug and ferric heme binding to human serum albumin.
Journal: The FEBS journal 20051201
Title: Use of acid-reducing agents in protease inhibitor-based HAART and the potential for negative treatment outcomes.
Journal: The AIDS reader 20051201
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20051201
Title: Atazanavir/ritonavir versus lopinavir/ritonavir: equivalent or different efficacy profiles?
Journal: AIDS (London, England) 20051118
Title: Proton pump inhibitors do not reduce atazanavir concentrations in HIV-infected patients treated with ritonavir-boosted atazanavir.
Journal: AIDS (London, England) 20051104
Title: In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20051101
Title: Rash in an HIV-positive patient.
Journal: HIV medicine 20051101
Title: Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia.
Journal: The Journal of infectious diseases 20051015
Title: Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction.
Journal: AIDS (London, England) 20051014
Title: Use of bilirubin as a marker of adherence to atazanavir-based antiretroviral therapy.
Journal: AIDS (London, England) 20051014
Title: PI monotherapy effective as maintenance.
Journal: AIDS patient care and STDs 20051001
Title: Comparison of atazanavir with lopinavir/ritonavir in patients with prior protease inhibitor failure: a randomized multinational trial.
Journal: Current medical research and opinion 20051001
Title: Determination of atazanavir in human plasma using solid-phase extraction and high-performance liquid chromatography.
Journal: Journal of pharmaceutical and biomedical analysis 20050915
Title: Unexpected improvement of sexual dysfunction during atazanavir therapy.
Journal: AIDS (London, England) 20050902
Title: HIV protease inhibitors activate the unfolded protein response in macrophages: implication for atherosclerosis and cardiovascular disease.
Journal: Molecular pharmacology 20050901
Title: Therapeutic drug monitoring of atazanavir: surveillance of pharmacotherapy in the clinic.
Journal: British journal of clinical pharmacology 20050901
Title: Atazanavir inhibits P-glycoprotein and multidrug resistance-associated protein efflux activity.
Journal: Journal of acquired immune deficiency syndromes (1999) 20050815
Title: Novel P1 chain-extended HIV protease inhibitors possessing potent anti-HIV activity and remarkable inverse antiviral resistance profiles.
Journal: Bioorganic & medicinal chemistry letters 20050801
Title: Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapy.
Journal: The Journal of antimicrobial chemotherapy 20050801
Title: Co-administration of atazanavir with proton-pump inhibitors and H2 blockers.
Journal: Journal of acquired immune deficiency syndromes (1999) 20050801
Title: Steady-state pharmacokinetics of atazanavir given alone or in combination with saquinavir hard-gel capsules or amprenavir in HIV-1-infected patients.
Journal: European journal of clinical pharmacology 20050801
Title: Review of atazanavir: a novel HIV protease inhibitor.
Journal: Expert opinion on pharmacotherapy 20050801
Title: Comparison of HIV type 1 protease inhibitor susceptibility results in viral samples analyzed by phenotypic drug resistance assays and by six resistance algorithms: an analysis of a subpopulation of the CHORUS cohort.
Journal: AIDS research and human retroviruses 20050801
Title: An Italian approach to postmarketing monitoring: preliminary results from the SCOLTA (Surveillance Cohort Long-Term Toxicity Antiretrovirals) project on the safety of lopinavir/ritonavir.
Journal: Journal of acquired immune deficiency syndromes (1999) 20050701
Title: Conventional HPLC method used for simultaneous determination of the seven HIV protease inhibitors and nonnucleoside reverse transcription inhibitor efavirenz in human plasma.
Journal: Biological & pharmaceutical bulletin 20050701
Title: The role of diet, exercise and smoking in dyslipidaemia in HIV-infected patients with lipodystrophy.
Journal: HIV medicine 20050701
Title: New targets and new drugs in the treatment of HIV.
Journal: Enfermedades infecciosas y microbiologia clinica 20050701
Title: [New antiretroviral treatment modalities].
Journal: Presse medicale (Paris, France : 1983) 20050604
Title: Atazanavir: effects on P-glycoprotein transport and CYP3A metabolism in vitro.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20050601
Title: Switching to atazanavir improves metabolic disorders in antiretroviral-experienced patients with severe hyperlipidemia.
Journal: Journal of acquired immune deficiency syndromes (1999) 20050601
Title: Simultaneous quantitative assay of atazanavir and 6 other HIV protease inhibitors by isocratic reversed-phase liquid chromatography in human plasma.
Journal: Therapeutic drug monitoring 20050601
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20050601
Title: Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050525
Title: Lipodystrophy is associated with a low rate of treatment failure in HIV-positive patients switched to atazanavir.
Journal: Journal of acquired immune deficiency syndromes (1999) 20050501
Title: Impact of acid-suppressive therapy on virologic response to atazanavir-based regimens in antiretroviral-experienced patients: a case series.
Journal: Journal of acquired immune deficiency syndromes (1999) 20050501
Title: Emerging anti-HIV drugs.
Journal: Expert opinion on emerging drugs 20050501
Title: [Current status of HIV protease inhibitors].
Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20050501
Title: Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures.
Journal: AIDS (London, England) 20050429
Title: [New data on atazanavir/r]].
Journal: MMW Fortschritte der Medizin 20050425
Title: Atazanavir: a novel inhibitor of HIV-protease in haemodialysis.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20050401
Title: Simple and simultaneous determination of the hiv-protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir plus M8 nelfinavir metabolite and the nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma by reversed-phase liquid chromatography.
Journal: Therapeutic drug monitoring 20050401
Title: FDA notifications. BMS issues letter about omeprazole.
Journal: AIDS alert 20050401
Title: Insulin resistance, HIV infection, and anti-HIV therapies.
Journal: The AIDS reader 20050401
Title: Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus.
Journal: The American journal of medicine 20050401
Title: Atazanavir affects saquinavir.
Journal: AIDS patient care and STDs 20050401
Title: Evaluation of atazanavir Ctrough, atazanavir genotypic inhibitory quotient, and baseline HIV genotype as predictors of a 24-week virological response in highly drug-experienced, HIV-infected patients treated with unboosted atazanavir.
Journal: The new microbiologica 20050401
Title: Design of HIV-1 protease inhibitors active on multidrug-resistant virus.
Journal: Journal of medicinal chemistry 20050324
Title: Lack of interaction between atazanavir and lansoprazole.
Journal: AIDS (London, England) 20050324
Title: Impact of dyslipidemia associated with Highly Active Antiretroviral Therapy (HAART) on cardiovascular risk and life expectancy.
Journal: The American journal of cardiology 20050301
Title: Atazanavir not to be used with proton pump inhibitors.
Journal: AIDS patient care and STDs 20050201
Title: Avoid PPIs with atazanavir.
Journal: AIDS clinical care 20050201
Title: Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures.
Journal: AIDS (London, England) 20050128
Title: Atazanavir for treatment of HIV infection in clinical routine: efficacy, pharmacokinetics and safety.
Journal: European journal of medical research 20050128
Title: Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment.
Journal: BMC infectious diseases 20050101
Title: Boosted Reyataz comparable to Kaletra.
Journal: AIDS patient care and STDs 20050101
Title: Changes in lipids over twelve months after initiating protease inhibitor therapy among persons treated for HIV/AIDS.
Journal: Lipids in health and disease 20050101
Title: Atazanavir: the advent of a new generation of more convenient protease inhibitors.
Journal: HIV clinical trials 20050101
Title: The steady-state pharmacokinetics of nelfinavir in combination with tenofovir in HIV-infected patients.
Journal: Antiviral therapy 20050101
Title: Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome.
Journal: Current pharmaceutical design 20050101
Title: Drug-drug interactions and the pharmacotherapy of HIV infection.
Journal: Topics in HIV medicine : a publication of the International AIDS Society, USA 20050101
Title: Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir.
Journal: Clinical pharmacokinetics 20050101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20050101
Title: Quantification of antiretroviral drugs in dried blood spot samples by means of liquid chromatography/tandem mass spectrometry.
Journal: Rapid communications in mass spectrometry : RCM 20050101
Title: Atazanavir: a review of its use in the management of HIV infection.
Journal: Drugs 20050101
Title: Anti-HIV agents. Kaletra + atazanavir.
Journal: TreatmentUpdate 20050101
Title: Anti-HIV agents. Atazanavir vs. Kaletra.
Journal: TreatmentUpdate 20050101
Title: New Antiretroviral Therapies for Pediatric HIV Infection.
Journal: The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG 20050101
Title: Determination of atazanavir and other antiretroviral drugs (indinavir, amprenavir, nelfinavir and its active metabolite M8, saquinavir, ritonavir, lopinavir, nevirapine and efavirenz) plasma levels by high performance liquid chromatography with UV detection.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041225
Title: Atazanavir for the treatment of human immunodeficiency virus infection.
Journal: Pharmacotherapy 20041201
Title: Reyataz may cause EKG abnormality.
Journal: AIDS patient care and STDs 20041201
Title: Improved structure-activity relationship analysis of HIV-1 protease inhibitors using interaction kinetic data.
Journal: Journal of medicinal chemistry 20041118
Title: The effects of HIV protease inhibitors atazanavir and lopinavir/ritonavir on insulin sensitivity in HIV-seronegative healthy adults.
Journal: AIDS (London, England) 20041105
Title: Pharmacologic perspectives for once-daily antiretroviral therapy.
Journal: The Annals of pharmacotherapy 20041101
Title: Acute interstitial nephritis associated with atazanavir, a new protease inhibitor.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20041101
Title: Atazanavir: A novel once-daily protease inhibitor.
Journal: Drugs of today (Barcelona, Spain : 1998) 20041101
Title: [Therapeutic strategies for HIV infection: clinical approach with boost antiproteases in adults].
Journal: Medecine et maladies infectieuses 20041101
Title: Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041015
Title: Pseudoaneurysm of the femoral artery in a HIV-infected man.
Journal: European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 20041001
Title: Atazanavir.
Journal: The Annals of pharmacotherapy 20041001
Title: Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1.
Journal: PLoS medicine 20041001
Title: Binding of anti-HIV drugs to human serum albumin.
Journal: IUBMB life 20041001
Title: HIV-chemotherapy and -prophylaxis: new drugs, leads and approaches.
Journal: The international journal of biochemistry & cell biology 20040901
Title: Recent changes to FDA-approved labeling.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20040901
Title: New dosing regimen for atazanavir.
Journal: AIDS patient care and STDs 20040901
Title: Management of HIV-infected patients with multidrug-resistant virus.
Journal: Current HIV/AIDS reports 20040901
Title: Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIV.
Journal: Journal of acquired immune deficiency syndromes (1999) 20040815
Title: Resistance to HIV protease inhibitors: mechanisms and clinical consequences.
Journal: Current drug metabolism 20040801
Title: Acute hepatic cytolysis in an HIV-infected patient taking atazanavir.
Journal: AIDS (London, England) 20040723
Title: Atazanavir: a new protease inhibitor to treat HIV infection.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20040701
Title: Atazanavir enhances saquinavir hard-gel concentrations in a ritonavir-boosted once-daily regimen.
Journal: AIDS (London, England) 20040618
Title: Antiviral drugs in current clinical use.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20040601
Title: Atazanavir: new option for treatment of HIV infection.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040601
Title: Long-term efficacy and safety of atazanavir with stavudine and lamivudine in patients previously treated with nelfinavir or atazanavir.
Journal: Journal of acquired immune deficiency syndromes (1999) 20040601
Title: The influence of protease inhibitor resistance profiles on selection of HIV therapy in treatment-naive patients.
Journal: Antiviral therapy 20040601
Title: [Recent progress in anti-HIM-1 research].
Journal: Uirusu 20040601
Title: Simultaneous quantification of the new HIV protease inhibitors atazanavir and tipranavir in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040525
Title: Identification of I50L as the signature atazanavir (ATV)-resistance mutation in treatment-naive HIV-1-infected patients receiving ATV-containing regimens.
Journal: The Journal of infectious diseases 20040515
Title: [New treatment options for HIV-infected patients].
Journal: Deutsche medizinische Wochenschrift (1946) 20040507
Title: Does atazanavir cause lipodystrophy?
Journal: Journal of HIV therapy 20040501
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20040501
Title: [Simplified HIV therapy. Atazanavir: the first protease inhibitor with once daily administration].
Journal: MMW Fortschritte der Medizin 20040426
Title: [Long-term tolerance. Favorable lipid profile--favorable effect on development of lipodystrophy?].
Journal: MMW Fortschritte der Medizin 20040426
Title: [Interview with Professor Jürgen Rockstroh, director of the Bonn University Clinic. Atazanavir in general practice].
Journal: MMW Fortschritte der Medizin 20040426
Title: [Good experiences with saquinavir. Double boosting of protease inhibitors gains significance].
Journal: MMW Fortschritte der Medizin 20040426
Title: [Atazanavir protects lipid metabolism. New PI with favorable metabolic profile].
Journal: MMW Fortschritte der Medizin 20040426
Title: Regression of lipodystrophy in HIV-infected patients under therapy with the new protease inhibitor atazanavir.
Journal: AIDS (London, England) 20040409
Title: Cross-resistance patterns among HIV protease inhibitors.
Journal: AIDS patient care and STDs 20040401
Title: Atazanavir (Reyataz): new recommendations if combined with tenofovir (Viread) -- and warning on Viagra, Cialis, and Levitra.
Journal: AIDS treatment news 20040326
Title: Optimizing dosing strategies for the combination of atazanavir plus saquinavir.
Journal: AIDS (London, England) 20040305
Title: Drug-induced liver injury associated with antiretroviral therapy that includes HIV-1 protease inhibitors.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040301
Title: Kinetic and thermodynamic characterization of HIV-1 protease inhibitors.
Journal: Journal of molecular recognition : JMR 20040101
Title: New drugs of 2003.
Journal: Journal of the American Pharmacists Association : JAPhA 20040101
Title: Initial therapy for human immunodeficiency virus: broadening the options.
Journal: HIV clinical trials 20040101
Title: Boosted Reyataz: 48-week results.
Journal: GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies 20040101
Title: Peptidomimetic inhibitors of HIV protease.
Journal: Current topics in medicinal chemistry 20040101
Title: Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics.
Journal: Clinical pharmacokinetics 20040101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20040101
Title: The pipeline: three to watch.
Journal: BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation 20040101
Title: Predictors of virological response to atazanavir in protease inhibitor-experienced patients.
Journal: HIV clinical trials 20040101
Title: Practical guidelines to interpret plasma concentrations of antiretroviral drugs.
Journal: Clinical pharmacokinetics 20040101
Title: Pharmacokinetics of antiretrovirals in pregnant women.
Journal: Clinical pharmacokinetics 20040101
Title: Atazanavir--a once-daily HIV protease inhibitor that does not cause dyslipidemia in newly treated patients: results from two randomized clinical trials.
Journal: Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20040101
Title: Strategies for overcoming resistance in HIV-1 infected patients receiving HAART.
Journal: AIDS reviews 20040101
Title: Warning: do not combine Reyataz and Prilosec.
Journal: AIDS treatment news 20040101
Title: Anti-HIV agents. Atazanavir and saquinavir.
Journal: TreatmentUpdate 20040101
Title: [Are all boosted protease inhibitors the same? Previously treated patients profit too from lopinavir/r].
Journal: MMW Fortschritte der Medizin 20031211
Title: Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjects: 48-week results.
Journal: AIDS (London, England) 20031205
Title: Pharmacokinetics of amprenavir given once or twice a day when combined with atazanavir in heavily pre-treated HIV-positive patients.
Journal: AIDS (London, England) 20031205
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20031201
Title: The continuing evolution of HIV therapy.
Journal: The AIDS reader 20031201
Title: Atazanavir (Reyataz) and emtricitabine (Emtriva) for HIV infection.
Journal: The Medical letter on drugs and therapeutics 20031110
Title: Atazanavir sulphate.
Journal: Nature reviews. Drug discovery 20031101
Title: New anti-HIV protease inhibitors provide more treatment options.
Journal: AIDS patient care and STDs 20031101
Title: Liquid chromatography-tandem mass spectrometric quantitative determination of the HIV protease inhibitor atazanavir (BMS-232632) in human peripheral blood mononuclear cells (PBMC): practical approaches to PBMC preparation and PBMC assay design for high-throughput analysis.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20031005
Title: Releasing the true power of protease inhibitors.
Journal: International journal of STD & AIDS 20031001
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20031001
Title: Atazanavir (Reyataz).
Journal: Project Inform perspective 20031001
Title: Atazanavir: improving the HIV protease inhibitor class.
Journal: Expert review of anti-infective therapy 20031001
Title: Reyataz.
Journal: Discovery medicine 20031001
Title: [Atazanavir--first protease inhibitor for one dose administration].
Journal: Deutsche medizinische Wochenschrift (1946) 20030926
Title: Boosted PIs: competition hots up.
Journal: The AIDS reader 20030901
Title: Meeting notes from the 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment. Atazanavir in treatment-experienced patients.
Journal: AIDS clinical care 20030901
Title: BMS issues PK notice regarding ATV + TDF.
Journal: IAPAC monthly 20030901
Title: FDA notifications. Reyataz is approved for HIV treatment.
Journal: AIDS alert 20030901
Title: [New protease inhibitor against HIV. Viral load decreases--without lipid increase].
Journal: MMW Fortschritte der Medizin 20030821
Title: HIV therapeutics, continued: another HIV protease inhibitor approved.
Journal: The AIDS reader 20030801
Title: Atazanavir: clinical use.
Journal: The Hopkins HIV report : a bimonthly newsletter for healthcare providers 20030701
Title: Drug profile: atazanavir (Reyataz, ATV).
Journal: The Hopkins HIV report : a bimonthly newsletter for healthcare providers 20030701
Title: New protease inhibitor atazanavir (Reyataz) approved.
Journal: AIDS treatment news 20030627
Title: Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: a randomized comparative pilot trial.
Journal: AIDS (London, England) 20030613
Title: Application of the Lewis acid-Lewis base bifunctional asymmetric catalysts to pharmaceutical syntheses: stereoselective chiral building block syntheses of human immunodeficiency virus (HIV) protease inhibitor and beta3-adenergic receptor agonist.
Journal: Chemical & pharmaceutical bulletin 20030601
Title: Reyataz dosing options discussed. Excerpts from the FDA atazanavir hearing.
Journal: GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies 20030601
Title: Reviving protease inhibitors: new data and more options.
Journal: Journal of acquired immune deficiency syndromes (1999) 20030601
Title: Atazanavir gets FDA Advisory Committee's thumbs-up.
Journal: IAPAC monthly 20030601
Title: Atazanavir background documents available.
Journal: AIDS treatment news 20030530
Title: Quantitative determination of the HIV protease inhibitor atazanavir (BMS-232632) in human plasma by liquid chromatography-tandem mass spectrometry following automated solid-phase extraction.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030525
Title: Distinct cross-resistance profiles of the new protease inhibitors amprenavir, lopinavir, and atazanavir in a panel of clinical samples.
Journal: AIDS (London, England) 20030523
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20030501
Title: [Antiretroviral therapy 2003. The current status].
Journal: MMW Fortschritte der Medizin 20030428
Title: [Highly effective drug without modifying the lipid profile. Atazanavir, the protease inhibitor for 'once daily' administration].
Journal: MMW Fortschritte der Medizin 20030428
Title: ['Once daily' drugs simplify therapy. Rp. HAART once daily].
Journal: MMW Fortschritte der Medizin 20030428
Title: New antiretroviral drugs.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20030301
Title: Gateways to clinical trials. March 2003.
Journal: Methods and findings in experimental and clinical pharmacology 20030301
Title: [Highly effective and tolerable protease inhibitor. New trump card against HIV].
Journal: MMW Fortschritte der Medizin 20030116
Title: Results of a phase 2 clinical trial at 48 weeks (AI424-007): a dose-ranging, safety, and efficacy comparative trial of atazanavir at three doses in combination with didanosine and stavudine in antiretroviral-naive subjects.
Journal: Journal of acquired immune deficiency syndromes (1999) 20030101
Title: Atazanavir found to help improve lipid profile. IDSA study offers good news for HIV care.
Journal: AIDS alert 20030101
Title: Anti-HIV drug updates--three drugs on the near horizon.
Journal: Project Inform perspective 20030101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20030101
Title: Atazanavir.
Journal: Drugs 20030101
Title: First once-daily protease inhibitor.
Journal: FDA consumer 20030101
Title: Three new drugs approved by FDA.
Journal: Survival news (Atlanta, Ga.) 20030101
Title: Anti-HIV agents. Atazanavir as a booster for protease inhibitors.
Journal: TreatmentUpdate 20030101
Title: Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Atazanavir--booster of the future?
Journal: TreatmentUpdate 20030101
Title: [Simple, safe and effective. New protease inhibitor means progress].
Journal: MMW Fortschritte der Medizin 20021205
Title: Overcoming obstacles to the success of protease inhibitors in highly active antiretroviral therapy regimens.
Journal: AIDS patient care and STDs 20021201
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20021101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20021001
Title: Atazanavir: a novel HIV-1 protease inhibitor.
Journal: Expert opinion on investigational drugs 20020901
Title: Gateways to Clinical Trials.
Journal: Methods and findings in experimental and clinical pharmacology 20020901
Title: [New protease inhibitor atazanavir. Simple administration--less resistance].
Journal: MMW Fortschritte der Medizin 20020808
Title: In vitro antiviral interaction of lopinavir with other protease inhibitors.
Journal: Antimicrobial agents and chemotherapy 20020701
Title: [Improving resistance profile, simplifying administration mode. New antiretroviral drugs].
Journal: MMW Fortschritte der Medizin 20020409
Title: [New HIV-1 protease inhibitors in development].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20020401
Title: Gateways to Clinical Trials.
Journal: Methods and findings in experimental and clinical pharmacology 20020401
Title: Highlights in the development of new antiviral agents.
Journal: Mini reviews in medicinal chemistry 20020401
Title: Promising new agents on the horizon.
Journal: AIDS clinical care 20020301
Title: Atazanavir demonstrates antiviral efficacy and a favorable lipid profile at 48 weeks.
Journal: The Journal of the Association of Nurses in AIDS Care : JANAC 20020101
Title: Drug giant Bristol-Myers Squibb: Atazanavir moves into the spotlight while O83 bites the dust.
Journal: Positively aware : the monthly journal of the Test Positive Aware Network 20020101
Title: [Progress toward a once daily regimen. (HA)ART--the art of antiretroviral therapy].
Journal: MMW Fortschritte der Medizin 20010402
Title: Hollow-fiber unit evaluation of a new human immunodeficiency virus type 1 protease inhibitor, BMS-232632, for determination of the linked pharmacodynamic variable.
Journal: The Journal of infectious diseases 20010401
Title: BMS-232632 (Novartis/Bristol-Myers Squibb).
Journal: Current opinion in investigational drugs (London, England : 2000) 20010301
Title: New antiretroviral agents.
Journal: The Hopkins HIV report : a bimonthly newsletter for healthcare providers 20010301
Title: A new protease inhibitor from Bristol-Myers Squibb.
Journal: TreatmentUpdate 20010101
Title: In vitro resistance profile of the human immunodeficiency virus type 1 protease inhibitor BMS-232632.
Journal: Antimicrobial agents and chemotherapy 20000901
Title: BMS-232632, a highly potent human immunodeficiency virus protease inhibitor that can be used in combination with other available antiretroviral agents.
Journal: Antimicrobial agents and chemotherapy 20000801
Title: Protease inhibitors: current status and future prospects.
Journal: Journal of medicinal chemistry 20000210
Title: New aza-dipeptide analogues as potent and orally absorbed HIV-1 protease inhibitors: candidates for clinical development.
Journal: Journal of medicinal chemistry 19980827
Title: Havlir DV, et al. Atazanavir: new option for treatment of HIV infection. Clin Infect Dis. 2004 Jun 1;38(11):1599-604.
Title: Wood R. Atazanavir: its role in HIV treatment. Expert Rev Anti Infect Ther. 2008 Dec;6(6):785-96.
Title: Qi Sun, et al. Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease. Signal Transduct Target Ther. 2021 May 29;6(1):212.
